| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G MYH1 MYH4 MYH8 ATP7B PSMC2 MCM2 SMC5 SUPV3L1 ATP13A3 KIF5C ABCC2 VCP HSPA4L DNAH2 FBH1 CHTF18 ATP6V0A4 ATP1A2 KIF13A ATP2A2 AQR | 1.75e-06 | 614 | 224 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH4 MYH8 ATP7B PSMC2 MCM2 SMC5 SUPV3L1 ATP13A3 KIF5C ABCC2 VCP DNAH2 FBH1 CHTF18 ATP1A2 KIF13A ATP2A2 AQR | 2.67e-06 | 441 | 224 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 5.53e-06 | 4 | 224 | 3 | GO:0004971 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO1G MYH1 MYH4 MYH8 PHACTR2 MYLK PARVB CLTC CCSER2 KIF5C ANK1 ANK2 ANK3 STXBP5L NCKIPSD APBB1 GRIA2 PRC1 LCP1 PTPRT SPTBN4 PARVA KIRREL1 CTNNA2 KIF13A CDH1 EP300 EPB41L1 EPB41L2 HTT | 6.00e-06 | 1099 | 224 | 30 | GO:0008092 |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.12e-05 | 27 | 224 | 5 | GO:0008066 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 3.27e-05 | 17 | 224 | 4 | GO:0004970 | |
| GeneOntologyMolecularFunction | spectrin binding | 3.63e-05 | 34 | 224 | 5 | GO:0030507 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 4.82e-05 | 36 | 224 | 5 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 4.82e-05 | 36 | 224 | 5 | GO:0015662 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 6.33e-05 | 120 | 224 | 8 | GO:0008013 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.37e-04 | 24 | 224 | 4 | GO:0099507 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 1.37e-04 | 24 | 224 | 4 | GO:0008093 | |
| GeneOntologyMolecularFunction | STAT family protein binding | 3.67e-04 | 13 | 224 | 3 | GO:0097677 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.74e-04 | 118 | 224 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 4.43e-04 | 57 | 224 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH4 MYH8 ATP7B PSMC2 MCM2 SMC5 SUPV3L1 GNL2 ATP13A3 KIF5C ABCC2 VCP DNAH2 FBH1 CHTF18 ATP1A2 RAP2C KIF13A ATP2A2 AQR | 4.83e-04 | 775 | 224 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 5.49e-04 | 34 | 224 | 4 | GO:0050750 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 5.62e-04 | 60 | 224 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | kinase binding | DOCK4 ILK RPS18 LYST RYR2 PTPN2 TELO2 TAX1BP1 CLTC RAF1 ANK2 PTPN23 GRIA2 NBEA TRIM68 PRC1 PRKCD SMCR8 CDH1 CEACAM20 EP300 PCNA HTT | 5.88e-04 | 969 | 224 | 23 | GO:0019900 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP7B RYR2 RYR3 SCN4A SLC39A6 ATP13A3 ANO2 GRIA2 GRIA3 GRIA4 GRID2 GRIK4 CACHD1 APOL1 SLC4A3 SLC9A4 ATP6V0A4 LRRC8A ATP1A2 ATP2A2 | 6.43e-04 | 793 | 224 | 20 | GO:0015075 |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 6.54e-04 | 62 | 224 | 5 | GO:0019829 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 7.41e-04 | 4 | 224 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 8.12e-04 | 65 | 224 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 8.12e-04 | 65 | 224 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 8.44e-04 | 38 | 224 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | protein kinase binding | DOCK4 ILK RPS18 LYST RYR2 PTPN2 TELO2 CLTC RAF1 ANK2 PTPN23 GRIA2 NBEA TRIM68 PRC1 PRKCD SMCR8 CDH1 CEACAM20 EP300 PCNA | 8.63e-04 | 873 | 224 | 21 | GO:0019901 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 9.32e-04 | 39 | 224 | 4 | GO:0070325 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP7B SLC25A25 RYR2 RYR3 SCN4A SLC39A6 ABCC2 ANO2 GRIA2 GRIA3 GRIA4 GRIK4 CACHD1 APOL1 SLC4A3 SLC9A4 ATP6V0A4 ATP1A2 ATP2A2 | 9.43e-04 | 758 | 224 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | calmodulin binding | 1.20e-03 | 230 | 224 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RABEP2 DOCK4 PHACTR2 DOCK11 ARHGAP26 PLEKHG5 ITIH3 NLRC4 SERPINB6 SERPINI2 RAB3GAP2 C3 TESC MCF2L DOCK6 VCP ARAP2 PPP4R1 RAF1 STXBP5L LCN1 RING1 ARFGAP2 PARVA DGKI PRKCD SMCR8 PCNA PLCE1 | 1.25e-03 | 1418 | 224 | 29 | GO:0030234 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH4 MYH8 ATP7B PSMC2 MCM2 SMC5 SUPV3L1 GNL2 ATP13A3 KIF5C ABCC2 VCP DNAH2 FBH1 CHTF18 ATP1A2 RAP2C KIF13A ATP2A2 AQR | 1.28e-03 | 839 | 224 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH4 MYH8 ATP7B PSMC2 MCM2 SMC5 SUPV3L1 GNL2 ATP13A3 KIF5C ABCC2 VCP DNAH2 FBH1 CHTF18 ATP1A2 RAP2C KIF13A ATP2A2 AQR | 1.29e-03 | 840 | 224 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH4 MYH8 ATP7B PSMC2 MCM2 SMC5 SUPV3L1 GNL2 ATP13A3 KIF5C ABCC2 VCP DNAH2 FBH1 CHTF18 ATP1A2 RAP2C KIF13A ATP2A2 AQR | 1.29e-03 | 840 | 224 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.44e-03 | 109 | 224 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.55e-03 | 193 | 224 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.55e-03 | 75 | 224 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.74e-03 | 77 | 224 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.76e-03 | 197 | 224 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 1.82e-03 | 6 | 224 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | 3'-5' RNA helicase activity | 1.82e-03 | 6 | 224 | 2 | GO:0034458 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.82e-03 | 6 | 224 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RABEP2 DOCK4 DOCK11 ARHGAP26 PLEKHG5 RAB3GAP2 MCF2L DOCK6 ARAP2 STXBP5L ARFGAP2 DGKI SMCR8 PLCE1 | 1.83e-03 | 507 | 224 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RABEP2 DOCK4 DOCK11 ARHGAP26 PLEKHG5 RAB3GAP2 MCF2L DOCK6 ARAP2 STXBP5L ARFGAP2 DGKI SMCR8 PLCE1 | 1.83e-03 | 507 | 224 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | calcium ion binding | CDHR1 MATN2 SLC25A25 RYR2 RYR3 CABYR CCDC47 ASTN2 TESC PCLO PCDHA12 LCP1 CELSR2 HMCN1 SUSD1 UNC13C CDH1 ATP2A2 | 2.03e-03 | 749 | 224 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | ankyrin binding | 2.09e-03 | 23 | 224 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor binding | 2.54e-03 | 7 | 224 | 2 | GO:0034190 | |
| GeneOntologyMolecularFunction | actin binding | MYO1G MYH1 MYH4 MYH8 PHACTR2 MYLK PARVB LCP1 SPTBN4 PARVA CTNNA2 EPB41L1 EPB41L2 | 3.06e-03 | 479 | 224 | 13 | GO:0003779 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYO1G MYH4 MYH8 PHACTR2 ILK ARHGAP26 PARVB RYR2 KANK1 SCN4A LURAP1 CDC42BPA ANK2 CARMIL1 PCLO SPECC1L LCP1 KANK2 SPTBN4 LIMK2 HMCN1 PARVA KIRREL1 PRKCD CTNNA2 ATP1A2 CDH1 ATP2A2 EP300 EPB41L1 EPB41L2 | 1.60e-08 | 912 | 223 | 31 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYO1G PHACTR2 ILK ARHGAP26 PARVB KANK1 LURAP1 CDC42BPA CARMIL1 PCLO SPECC1L LCP1 KANK2 SPTBN4 LIMK2 HMCN1 PARVA KIRREL1 PRKCD CTNNA2 CDH1 EP300 EPB41L1 EPB41L2 | 7.00e-06 | 803 | 223 | 24 | GO:0030036 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATP7B TMEM74 SLC25A25 RYR2 RYR3 SCN4A SLC39A6 ATP13A3 TESC ABCC2 PCSK9 ANO2 ANK2 ANK3 GRIA2 GRIA3 GRIA4 GRID2 GRIK4 CACHD1 APOL1 SLC4A3 SLC9A4 ATP6V0A4 LRRC8A ATP1A2 ATP2A2 HTT PLCE1 | 1.08e-05 | 1115 | 223 | 29 | GO:0034220 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | RABEP2 MYLK DOCK11 PARVB CCDC13 KANK1 PLD1 CPLANE1 CARMIL1 DNAH2 PTPN23 WDR19 LIMK2 CELSR2 PARVA PRKCD CFAP57 RAP2C HYDIN HTT PLCE1 | 1.34e-05 | 670 | 223 | 21 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | RABEP2 MYLK DOCK11 PARVB CCDC13 KANK1 PLD1 CPLANE1 CARMIL1 DNAH2 PTPN23 WDR19 LIMK2 CELSR2 PARVA PRKCD CFAP57 RAP2C HYDIN HTT PLCE1 | 1.86e-05 | 685 | 223 | 21 | GO:0030031 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ATP7B MYLK TMEM74 SLC25A25 RYR2 RYR3 SCN4A CLTC SLC39A6 ATP13A3 TESC ABCC2 PCSK9 ANO2 ANK2 ANK3 GRIA2 GRIA3 GRIA4 GRID2 GRIK4 CACHD1 APOL1 SLC4A3 SPTBN4 SLC9A4 ATP6V0A4 LRRC8A ATP1A2 ATP2A2 HTT PLCE1 | 3.32e-05 | 1374 | 223 | 32 | GO:0006811 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 4.41e-05 | 87 | 223 | 7 | GO:0086001 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 4.45e-05 | 153 | 223 | 9 | GO:0030048 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 7.33e-05 | 127 | 223 | 8 | GO:0070252 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 9.61e-05 | 132 | 223 | 8 | GO:0035249 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 1.09e-04 | 44 | 223 | 5 | GO:0070296 | |
| GeneOntologyCellularComponent | lamellipodium | MYO1G ILK MYLK PARVB PLEKHG5 SLC39A6 TESC PLD1 MCF2L CDC42BPA CARMIL1 APBB1 PARVA CTNNA2 CDH1 PLCE1 | 4.28e-09 | 230 | 225 | 16 | GO:0030027 |
| GeneOntologyCellularComponent | anchoring junction | MYH1 GAK ILK ATP7B MYLK ARHGAP26 RPS18 PARVB PLEKHG5 CLTC ABCC2 CDC42BPA ANK2 ANK3 PCDHA12 SPECC1L LCP1 AKAP12 SPTBN4 HMCN1 PARVA KIRREL1 PRKCD CTNNA2 ATP1A2 PATJ RAP2C CDH1 ATP2A2 EPB41L2 PDZD2 | 6.80e-08 | 976 | 225 | 31 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell junction | MYH1 ILK ATP7B MYLK PLEKHG5 ABCC2 CDC42BPA ANK2 ANK3 PCDHA12 SPECC1L SPTBN4 HMCN1 KIRREL1 PRKCD CTNNA2 ATP1A2 PATJ RAP2C CDH1 ATP2A2 PDZD2 | 4.72e-07 | 591 | 225 | 22 | GO:0005911 |
| GeneOntologyCellularComponent | cell leading edge | MYO1G ILK MYLK PARVB PLEKHG5 KANK1 SLC39A6 TESC PLD1 MCF2L CDC42BPA ANK1 CARMIL1 APBB1 GRIA2 LCP1 PARVA CTNNA2 CDH1 PLCE1 | 5.29e-07 | 500 | 225 | 20 | GO:0031252 |
| GeneOntologyCellularComponent | sarcomere | MYH1 MYH4 MYH8 ILK STYXL2 PARVB RYR2 RYR3 GRK3 ANK1 ANK2 ANK3 PARVA AHNAK2 | 5.60e-07 | 249 | 225 | 14 | GO:0030017 |
| GeneOntologyCellularComponent | myofibril | MYH1 MYH4 MYH8 ILK STYXL2 PARVB RYR2 RYR3 GRK3 ANK1 ANK2 ANK3 PARVA AHNAK2 | 1.67e-06 | 273 | 225 | 14 | GO:0030016 |
| GeneOntologyCellularComponent | endosome | RABEP2 IL12B ATP7B INPP4A ARHGAP26 PTPN2 AP1S1 CLTC SNX31 ASTN2 ATP13A3 PLD1 VCAM1 PCSK9 GPC1 CHMP4C ANK2 CARMIL1 PTPN23 APOB SEC31A ECPAS MTMR4 ATP6V0A4 PRKCD ATP1A2 RAP2C KIF13A CDH1 HTT DOP1A | 3.13e-06 | 1167 | 225 | 31 | GO:0005768 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH1 MYH4 MYH8 ILK STYXL2 PARVB RYR2 RYR3 GRK3 ANK1 ANK2 ANK3 PARVA AHNAK2 | 3.39e-06 | 290 | 225 | 14 | GO:0043292 |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 6.36e-06 | 43 | 225 | 6 | GO:0098688 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 8.00e-06 | 94 | 225 | 8 | GO:0044291 | |
| GeneOntologyCellularComponent | terminal bouton | 9.35e-06 | 96 | 225 | 8 | GO:0043195 | |
| GeneOntologyCellularComponent | postsynapse | INPP4A PSMC2 RPS18 GRK3 CLTC KIF5C ANK1 ANK2 ANK3 PCLO APBB1 GRIA2 GRIA3 GRIA4 GRID2 NBEA GRIK4 LRRC4C PTPRT DGKI PRKCD CTNNA2 ATP1A2 SMCR8 CDH1 EPB41L1 HTT | 1.48e-05 | 1018 | 225 | 27 | GO:0098794 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.80e-05 | 137 | 225 | 9 | GO:0019897 | |
| GeneOntologyCellularComponent | synaptic membrane | CLTC ANO2 ANK1 ANK2 ANK3 APBB1 GRIA2 GRIA3 GRIA4 GRID2 NBEA GRIK4 LRRC4C PTPRT DGKI UNC13C CTNNA2 EPB41L1 HTT | 1.94e-05 | 583 | 225 | 19 | GO:0097060 |
| GeneOntologyCellularComponent | excitatory synapse | 2.08e-05 | 107 | 225 | 8 | GO:0060076 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | GAK ATP7B TSNAX PLEKHG5 RYR3 GRK3 PLD1 DOCK6 EIF2AK3 VCP PCSK9 ANK2 PCLO APBB1 SEC31A TRIM68 LCP1 LIMK2 DGKI KIRREL1 PRKCD PATJ CDH1 ATP2A2 HTT | 2.69e-05 | 934 | 225 | 25 | GO:0048471 |
| GeneOntologyCellularComponent | postsynaptic density | INPP4A RPS18 GRK3 ANK2 ANK3 PCLO GRIA2 GRIA3 GRIA4 GRID2 GRIK4 LRRC4C PTPRT DGKI CTNNA2 EPB41L1 | 3.28e-05 | 451 | 225 | 16 | GO:0014069 |
| GeneOntologyCellularComponent | Z disc | 3.89e-05 | 151 | 225 | 9 | GO:0030018 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | TRAF3IP2 RYR2 CLTC GML MCF2L PCSK9 ANK2 DGKI CTNNA2 CDH1 ATP2A2 | 4.20e-05 | 230 | 225 | 11 | GO:0019898 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO1G MYH1 MYH4 MYH8 ILK MYLK PARVB VCAM1 LURAP1 CDC42BPA CARMIL1 SPECC1L LCP1 SPTBN4 PARVA CTNNA2 CDH1 EPB41L2 | 5.56e-05 | 576 | 225 | 18 | GO:0015629 |
| GeneOntologyCellularComponent | asymmetric synapse | INPP4A RPS18 GRK3 ANK2 ANK3 PCLO GRIA2 GRIA3 GRIA4 GRID2 GRIK4 LRRC4C PTPRT DGKI CTNNA2 EPB41L1 | 6.38e-05 | 477 | 225 | 16 | GO:0032279 |
| GeneOntologyCellularComponent | I band | 8.11e-05 | 166 | 225 | 9 | GO:0031674 | |
| GeneOntologyCellularComponent | costamere | 8.21e-05 | 22 | 225 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | intercalated disc | 9.13e-05 | 68 | 225 | 6 | GO:0014704 | |
| GeneOntologyCellularComponent | axon terminus | 9.72e-05 | 210 | 225 | 10 | GO:0043679 | |
| GeneOntologyCellularComponent | postsynaptic specialization | INPP4A RPS18 GRK3 ANK2 ANK3 PCLO GRIA2 GRIA3 GRIA4 GRID2 GRIK4 LRRC4C PTPRT DGKI CTNNA2 EPB41L1 | 1.18e-04 | 503 | 225 | 16 | GO:0099572 |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.19e-04 | 45 | 225 | 5 | GO:0008328 | |
| GeneOntologyCellularComponent | postsynaptic membrane | ANK1 ANK2 ANK3 APBB1 GRIA2 GRIA3 GRIA4 GRID2 NBEA GRIK4 LRRC4C PTPRT DGKI CTNNA2 | 1.34e-04 | 405 | 225 | 14 | GO:0045211 |
| GeneOntologyCellularComponent | presynaptic active zone | 1.48e-04 | 141 | 225 | 8 | GO:0048786 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH1 MYH4 MYH8 ILK STYXL2 PARVB TUBA8 RYR2 RYR3 CEP170 GRK3 CLTC KIF5C CHMP4C ANK1 ANK2 ANK3 CARMIL1 NCKIPSD DNAH2 SPECC1L PRC1 LCP1 SPTBN4 PARVA KIF13A AHNAK2 | 1.78e-04 | 1179 | 225 | 27 | GO:0099512 |
| GeneOntologyCellularComponent | neuron to neuron synapse | INPP4A RPS18 GRK3 ANK2 ANK3 PCLO GRIA2 GRIA3 GRIA4 GRID2 GRIK4 LRRC4C PTPRT DGKI CTNNA2 EPB41L1 | 1.84e-04 | 523 | 225 | 16 | GO:0098984 |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 1.85e-04 | 185 | 225 | 9 | GO:0009898 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 1.97e-04 | 50 | 225 | 5 | GO:0098878 | |
| GeneOntologyCellularComponent | supramolecular polymer | MYH1 MYH4 MYH8 ILK STYXL2 PARVB TUBA8 RYR2 RYR3 CEP170 GRK3 CLTC KIF5C CHMP4C ANK1 ANK2 ANK3 CARMIL1 NCKIPSD DNAH2 SPECC1L PRC1 LCP1 SPTBN4 PARVA KIF13A AHNAK2 | 1.98e-04 | 1187 | 225 | 27 | GO:0099081 |
| GeneOntologyCellularComponent | sarcolemma | 2.25e-04 | 190 | 225 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | neuron projection terminus | 2.27e-04 | 233 | 225 | 10 | GO:0044306 | |
| GeneOntologyCellularComponent | axon | ILK PLEKHG5 RXRA AP1S1 GRK3 CRCP SCN4A KIF5C ANK1 ANK3 PCLO APBB1 GRIA2 GRIA3 GRIA4 GRIK4 SPTBN4 DGKI UNC13C CTNNA2 CDH1 HTT | 2.63e-04 | 891 | 225 | 22 | GO:0030424 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.08e-04 | 157 | 225 | 8 | GO:0098839 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 3.38e-04 | 56 | 225 | 5 | GO:0031234 | |
| GeneOntologyCellularComponent | glutamatergic synapse | INPP4A FAAH GRK3 CLTC VCP ANO2 PPFIA4 PCLO APBB1 GRIA2 GRIA3 GRIA4 GRID2 NBEA GRIK4 LRRC4C PTPRT DGKI CDH1 HTT | 5.59e-04 | 817 | 225 | 20 | GO:0098978 |
| GeneOntologyCellularComponent | presynapse | GAK ILK PLEKHG5 AP1S1 GRK3 CLTC ANO2 PPFIA4 PCLO APBB1 GRIA2 GRIA3 GRIA4 GRIK4 ATP6V0A4 DGKI UNC13C CTNNA2 SMCR8 CDH1 HTT | 6.18e-04 | 886 | 225 | 21 | GO:0098793 |
| GeneOntologyCellularComponent | muscle myosin complex | 6.21e-04 | 16 | 225 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | early endosome | RABEP2 INPP4A AP1S1 SNX31 ASTN2 ATP13A3 VCAM1 PCSK9 ANK2 PTPN23 APOB ECPAS MTMR4 HTT | 7.57e-04 | 481 | 225 | 14 | GO:0005769 |
| GeneOntologyCellularComponent | presynaptic membrane | 8.77e-04 | 277 | 225 | 10 | GO:0042734 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 9.00e-04 | 230 | 225 | 9 | GO:0098562 | |
| GeneOntologyCellularComponent | dendritic shaft | 1.22e-03 | 74 | 225 | 5 | GO:0043198 | |
| GeneOntologyCellularComponent | node of Ranvier | 1.23e-03 | 20 | 225 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | dendritic spine | 1.28e-03 | 242 | 225 | 9 | GO:0043197 | |
| GeneOntologyCellularComponent | neuromuscular junction | 1.35e-03 | 112 | 225 | 6 | GO:0031594 | |
| GeneOntologyCellularComponent | neuron spine | 1.48e-03 | 247 | 225 | 9 | GO:0044309 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.55e-03 | 201 | 225 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | T-tubule | 1.63e-03 | 79 | 225 | 5 | GO:0030315 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | RYR2 RYR3 SCN4A ANO2 GRIA2 GRIA3 GRIA4 GRID2 GRIK4 CACHD1 ATP6V0A4 LRRC8A ATP1A2 ATP2A2 | 1.67e-03 | 523 | 225 | 14 | GO:1902495 |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 1.68e-03 | 6 | 225 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.86e-03 | 23 | 225 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | A band | 2.36e-03 | 52 | 225 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | myosin filament | 2.38e-03 | 25 | 225 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | cell projection membrane | PLB1 CDHR1 KANK1 SLC39A6 TESC ABCC2 ANK1 GRIA2 LCP1 ATP6V0A4 KIRREL1 CEACAM20 | 2.57e-03 | 431 | 225 | 12 | GO:0031253 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 2.62e-03 | 88 | 225 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | transporter complex | RYR2 RYR3 SCN4A ANO2 GRIA2 GRIA3 GRIA4 GRID2 GRIK4 CACHD1 ATP6V0A4 LRRC8A ATP1A2 ATP2A2 | 2.65e-03 | 550 | 225 | 14 | GO:1990351 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | RYR2 RYR3 SCN4A ANO2 GRIA2 GRIA3 GRIA4 GRID2 GRIK4 CACHD1 LRRC8A | 2.74e-03 | 378 | 225 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | main axon | 2.76e-03 | 89 | 225 | 5 | GO:0044304 | |
| GeneOntologyCellularComponent | distal axon | ILK AP1S1 KIF5C PCLO APBB1 GRIA2 GRIA3 GRIA4 GRIK4 DGKI UNC13C CDH1 | 2.77e-03 | 435 | 225 | 12 | GO:0150034 |
| GeneOntologyCellularComponent | myosin II complex | 3.30e-03 | 28 | 225 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | sodium channel complex | 3.66e-03 | 29 | 225 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | myosin complex | 3.74e-03 | 59 | 225 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 3.95e-03 | 9 | 225 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 3.95e-03 | 9 | 225 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | endolysosome | 4.03e-03 | 30 | 225 | 3 | GO:0036019 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 4.03e-03 | 30 | 225 | 3 | GO:0032281 | |
| GeneOntologyCellularComponent | ribbon synapse | 4.85e-03 | 32 | 225 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | endopeptidase complex | 4.94e-03 | 102 | 225 | 5 | GO:1905369 | |
| GeneOntologyCellularComponent | proteasome complex | 5.90e-03 | 67 | 225 | 4 | GO:0000502 | |
| GeneOntologyCellularComponent | postsynaptic endocytic zone | 5.95e-03 | 11 | 225 | 2 | GO:0098843 | |
| GeneOntologyCellularComponent | trans-Golgi network | 6.09e-03 | 306 | 225 | 9 | GO:0005802 | |
| MousePheno | impaired muscle contractility | MYH1 MYH4 RXRA RYR2 RYR3 SCN4A RAF1 ANK1 ANK2 NBEA KANSL1 ATP1A2 ATP2A2 EP300 PLCE1 | 8.48e-06 | 297 | 183 | 15 | MP:0000738 |
| MousePheno | abnormal muscle contractility | MYH1 MYH4 MYLK RXRA RYR2 RYR3 SCN4A RAF1 ANK1 ANK2 NBEA AKAP12 SPTBN4 KANSL1 ATP1A2 ATP2A2 EP300 PLCE1 | 9.56e-06 | 418 | 183 | 18 | MP:0005620 |
| MousePheno | prenatal lethality, incomplete penetrance | SOX10 ATXN2L ILK RGMA SALL1 CCDC47 SUPV3L1 CPLANE1 EIF2AK3 VCAM1 RAD21 REV1 RAF1 UBR2 ANK1 ANK3 APOB CHTF18 PARVA LRRC8A ATP2A2 EP300 PCNA HTT | 4.20e-05 | 747 | 183 | 24 | MP:0011101 |
| Domain | Lig_chan-Glu_bd | 1.79e-06 | 18 | 224 | 5 | PF10613 | |
| Domain | Glu/Gly-bd | 1.79e-06 | 18 | 224 | 5 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.79e-06 | 18 | 224 | 5 | SM00918 | |
| Domain | Iontro_rcpt | 1.79e-06 | 18 | 224 | 5 | IPR001320 | |
| Domain | Iono_rcpt_met | 1.79e-06 | 18 | 224 | 5 | IPR001508 | |
| Domain | Lig_chan | 1.79e-06 | 18 | 224 | 5 | PF00060 | |
| Domain | PBPe | 1.79e-06 | 18 | 224 | 5 | SM00079 | |
| Domain | PH_dom-like | DOCK11 ARHGAP26 PLEKHG5 LYST GRK3 PLD1 MCF2L ARAP2 CDC42BPA APBB1 NBEA SPTBN4 MTMR4 EPB41L1 EPB41L2 PLCE1 | 5.93e-05 | 426 | 224 | 16 | IPR011993 |
| Domain | ANF_lig-bd_rcpt | 7.57e-05 | 37 | 224 | 5 | IPR001828 | |
| Domain | ANF_receptor | 7.57e-05 | 37 | 224 | 5 | PF01094 | |
| Domain | Peripla_BP_I | 9.80e-05 | 39 | 224 | 5 | IPR028082 | |
| Domain | ZU5 | 1.36e-04 | 9 | 224 | 3 | SM00218 | |
| Domain | ZU5 | 1.92e-04 | 10 | 224 | 3 | PS51145 | |
| Domain | DHR-1_domain | 2.62e-04 | 11 | 224 | 3 | IPR027007 | |
| Domain | DHR_2 | 2.62e-04 | 11 | 224 | 3 | PS51651 | |
| Domain | DHR_1 | 2.62e-04 | 11 | 224 | 3 | PS51650 | |
| Domain | DHR-2 | 2.62e-04 | 11 | 224 | 3 | PF06920 | |
| Domain | DOCK | 2.62e-04 | 11 | 224 | 3 | IPR026791 | |
| Domain | DOCK_C | 2.62e-04 | 11 | 224 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 2.62e-04 | 11 | 224 | 3 | PF14429 | |
| Domain | DHR-2 | 2.62e-04 | 11 | 224 | 3 | IPR027357 | |
| Domain | - | DOCK11 ARHGAP26 PLEKHG5 GRK3 PLD1 MCF2L ARAP2 CDC42BPA APBB1 SPTBN4 MTMR4 EPB41L1 EPB41L2 PLCE1 | 2.81e-04 | 391 | 224 | 14 | 2.30.29.30 |
| Domain | ZU5 | 3.46e-04 | 12 | 224 | 3 | PF00791 | |
| Domain | ZU5_dom | 3.46e-04 | 12 | 224 | 3 | IPR000906 | |
| Domain | Ryanodine_rcpt | 4.26e-04 | 3 | 224 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 4.26e-04 | 3 | 224 | 2 | IPR009460 | |
| Domain | RyR | 4.26e-04 | 3 | 224 | 2 | PF02026 | |
| Domain | Parvin | 4.26e-04 | 3 | 224 | 2 | IPR028433 | |
| Domain | RR_TM4-6 | 4.26e-04 | 3 | 224 | 2 | PF06459 | |
| Domain | Ryan_recept | 4.26e-04 | 3 | 224 | 2 | IPR013333 | |
| Domain | - | 5.56e-04 | 32 | 224 | 4 | 3.40.1110.10 | |
| Domain | - | 5.56e-04 | 32 | 224 | 4 | 2.70.150.10 | |
| Domain | C1_1 | 5.98e-04 | 57 | 224 | 5 | PF00130 | |
| Domain | Myosin_N | 6.96e-04 | 15 | 224 | 3 | PF02736 | |
| Domain | Myosin_N | 6.96e-04 | 15 | 224 | 3 | IPR004009 | |
| Domain | ATPase_P-typ_cyto_domN | 7.88e-04 | 35 | 224 | 4 | IPR023299 | |
| Domain | - | 8.41e-04 | 92 | 224 | 6 | 3.90.190.10 | |
| Domain | - | 8.46e-04 | 4 | 224 | 2 | 3.90.1460.10 | |
| Domain | 4_1_CTD | 8.46e-04 | 4 | 224 | 2 | PF05902 | |
| Domain | KN_motif | 8.46e-04 | 4 | 224 | 2 | IPR021939 | |
| Domain | SAB | 8.46e-04 | 4 | 224 | 2 | PF04382 | |
| Domain | Band_4.1_C | 8.46e-04 | 4 | 224 | 2 | IPR008379 | |
| Domain | GTF2I | 8.46e-04 | 4 | 224 | 2 | PS51139 | |
| Domain | SAB_dom | 8.46e-04 | 4 | 224 | 2 | IPR007477 | |
| Domain | GTF2I | 8.46e-04 | 4 | 224 | 2 | PF02946 | |
| Domain | GTF2I | 8.46e-04 | 4 | 224 | 2 | IPR004212 | |
| Domain | KN_motif | 8.46e-04 | 4 | 224 | 2 | PF12075 | |
| Domain | ATPase_P-typ_P_site | 8.78e-04 | 36 | 224 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 8.78e-04 | 36 | 224 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 8.78e-04 | 36 | 224 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 9.75e-04 | 37 | 224 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 9.75e-04 | 37 | 224 | 4 | PF00122 | |
| Domain | ZF_DAG_PE_1 | 1.02e-03 | 64 | 224 | 5 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.02e-03 | 64 | 224 | 5 | PS50081 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.02e-03 | 17 | 224 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.02e-03 | 17 | 224 | 3 | PF00689 | |
| Domain | Myosin_head_motor_dom | 1.08e-03 | 38 | 224 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.08e-03 | 38 | 224 | 4 | PS51456 | |
| Domain | Myosin_head | 1.08e-03 | 38 | 224 | 4 | PF00063 | |
| Domain | MYSc | 1.08e-03 | 38 | 224 | 4 | SM00242 | |
| Domain | C1 | 1.09e-03 | 65 | 224 | 5 | SM00109 | |
| Domain | CH | 1.09e-03 | 65 | 224 | 5 | SM00033 | |
| Domain | PE/DAG-bd | 1.17e-03 | 66 | 224 | 5 | IPR002219 | |
| Domain | Myosin_tail_1 | 1.22e-03 | 18 | 224 | 3 | PF01576 | |
| Domain | Cation_ATPase_N | 1.22e-03 | 18 | 224 | 3 | PF00690 | |
| Domain | Myosin_tail | 1.22e-03 | 18 | 224 | 3 | IPR002928 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.23e-03 | 99 | 224 | 6 | IPR029021 | |
| Domain | Myosin-like_IQ_dom | 1.43e-03 | 19 | 224 | 3 | IPR027401 | |
| Domain | - | 1.43e-03 | 19 | 224 | 3 | 4.10.270.10 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.43e-03 | 19 | 224 | 3 | IPR004014 | |
| Domain | CH | 1.52e-03 | 70 | 224 | 5 | PF00307 | |
| Domain | - | 1.62e-03 | 71 | 224 | 5 | 1.10.418.10 | |
| Domain | CH | 1.84e-03 | 73 | 224 | 5 | PS50021 | |
| Domain | CH-domain | 2.07e-03 | 75 | 224 | 5 | IPR001715 | |
| Domain | RIH_assoc-dom | 2.08e-03 | 6 | 224 | 2 | IPR013662 | |
| Domain | PH_BEACH | 2.08e-03 | 6 | 224 | 2 | PF14844 | |
| Domain | Ins145_P3_rec | 2.08e-03 | 6 | 224 | 2 | PF08709 | |
| Domain | Haem_d1 | 2.08e-03 | 6 | 224 | 2 | IPR011048 | |
| Domain | DUF3398 | 2.08e-03 | 6 | 224 | 2 | PF11878 | |
| Domain | RIH_assoc | 2.08e-03 | 6 | 224 | 2 | PF08454 | |
| Domain | RIH_dom | 2.08e-03 | 6 | 224 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.08e-03 | 6 | 224 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.08e-03 | 6 | 224 | 2 | IPR015925 | |
| Domain | - | 2.08e-03 | 6 | 224 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.08e-03 | 6 | 224 | 2 | PF01365 | |
| Domain | DOCK_C/D_N | 2.08e-03 | 6 | 224 | 2 | IPR021816 | |
| Domain | HEAT | 2.59e-03 | 48 | 224 | 4 | PF02985 | |
| Domain | ARM-type_fold | DOCK11 NEK10 LYST RYR3 TELO2 CLTC PPP4R1 NBEA APOB ECPAS HTT | 2.71e-03 | 339 | 224 | 11 | IPR016024 |
| Domain | Clathrin | 2.89e-03 | 7 | 224 | 2 | PF00637 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 ATXN2L PHACTR2 AMER1 ILK GPBP1 DOCK11 LYST CEP170 RAB3GAP2 CCSER2 KIF5C DOCK6 ARAP2 RAF1 AMPD2 CDC42BPA CARMIL1 NCKIPSD APBB1 TRIM68 ARFGAP2 LIMK2 MTMR4 PATJ KIF13A EPB41L1 AQR EPB41L2 DOP1A AHNAK2 | 2.40e-14 | 861 | 231 | 31 | 36931259 |
| Pubmed | MYH1 MYH4 MYH8 PHACTR2 AMER1 MYLK LYST RYR2 PMPCA CCDC47 SCN4A CLTC GTF2IRD2 MLLT1 KIF5C ABCC2 MCF2L ANK2 HSPA4L PPFIA4 PCLO DNAH2 NUP98 CCDC127 GRIA2 GRIA3 GRIA4 APOB LCP1 SLC4A3 RING1 SPTBN4 GTF2IRD2B NMI SUSD1 ATP1A2 CDH1 ATP2A2 DOP1A | 8.25e-14 | 1442 | 231 | 39 | 35575683 | |
| Pubmed | DOCK4 ATXN2L PSMC2 RPS18 RYR2 CEP170 PTPN2 SERPINB6 RAB3GAP2 CLTC SLC39A6 VCP AMPD2 CDC42BPA ANK2 ANK3 STXBP5L UFC1 PCLO APBB1 GRIA2 GRIA3 GRIA4 NBEA LRRC4C ARFGAP2 CELSR2 CTNNA2 ATP1A2 ATP2A2 EPB41L1 EPB41L2 | 6.74e-12 | 1139 | 231 | 32 | 36417873 | |
| Pubmed | ATXN2L PSMC2 RPS18 CEP170 CCDC47 RAB3GAP2 EIF2AK3 VCP CDC42BPA ANK2 ANK3 HSPA4L CARMIL1 PTPN23 CACHD1 SEC31A ECPAS AKAP12 ARFGAP2 GEMIN4 PATJ SMCR8 ATP2A2 EPB41L1 EPB41L2 | 1.39e-11 | 708 | 231 | 25 | 39231216 | |
| Pubmed | GAK PSMC2 RPS18 TELO2 CCDC47 CLTC SLC39A6 VCP ANK2 APBB1 PTPN23 NBEA SEC31A ECPAS AKAP12 ARFGAP2 ATP2A2 EPB41L2 | 1.59e-09 | 449 | 231 | 18 | 31732153 | |
| Pubmed | RABEP2 DOCK11 CEP170 CCDC13 AP1S1 MORF4L1 TAX1BP1 CLTC KIF5C AMPD2 ANK2 ANK3 GRIA2 GRIA3 GRIA4 NBEA SEC31A SPECC1L KANK2 AKAP12 SPTBN4 CELSR2 DGKI CTNNA2 EPB41L1 EPB41L2 | 1.70e-09 | 963 | 231 | 26 | 28671696 | |
| Pubmed | DOCK4 SETD1B SMC5 SLC25A25 KANK1 ZFR2 RAB3GAP2 CLTC MCF2L ARAP2 UBR2 LRRC4C KANSL1 EPB41L1 AQR PLCE1 PDZD2 | 2.48e-09 | 407 | 231 | 17 | 12693553 | |
| Pubmed | SOX10 PARVB RYR3 CCDC13 SUPV3L1 MORF4L1 CLTC ASTN2 KIF5C VCP PPP4R1 LURAP1 ANK2 ANK3 APBB1 NBEA CACHD1 SEC31A TRIM68 KANK2 SLC4A3 WDR19 SPTBN4 FBH1 LRRCC1 ZNF76 ANKRD24 ATP1A2 ATP2A2 EP300 | 2.60e-09 | 1285 | 231 | 30 | 35914814 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATXN2L SETD1B GPBP1 DOCK11 MCM2 CEP170 CLTC CCSER2 GNL2 EIF2AK3 HSPA4L NUP98 RRP8 PRC1 CHTF18 CDH1 AQR | 7.90e-09 | 440 | 231 | 17 | 34244565 |
| Pubmed | ATXN2L GAK INPP4A ARHGAP26 RPS18 PLEKHG5 CEP170 CLTC MCAT KIF5C VCP GPC1 RAF1 ANK2 ANK3 HSPA4L PPFIA4 CARMIL1 PCLO NCKIPSD GRIA2 NBEA SPECC1L KANK2 SPTBN4 LRRCC1 CTNNA2 ATP1A2 ATP2A2 EPB41L1 EPB41L2 | 7.90e-09 | 1431 | 231 | 31 | 37142655 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | ILK PSMB7 MCM2 CEP170 RAB3GAP2 UGDH HSPA4L PCLO APBB1 PTPN23 NBEA ECPAS PARVA GEMIN4 CTNNA2 EPB41L1 AQR | 4.79e-08 | 498 | 231 | 17 | 36634849 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | GRK3 CLTC ANK2 ANK3 PCLO GRIA2 GRIA3 NBEA SPECC1L CTNNA2 EPB41L1 EPB41L2 PCNA | 6.01e-08 | 281 | 231 | 13 | 28706196 |
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 6.53e-08 | 7 | 231 | 4 | 7495297 | |
| Pubmed | 6.53e-08 | 7 | 231 | 4 | 21368048 | ||
| Pubmed | AMER1 RYR2 AP1S1 CLTC UGDH PLD1 ARAP2 CDC42BPA ANK3 NUP98 APBB1 NBEA APOB SEC31A SPECC1L AKAP12 ARFGAP2 KIRREL1 SMCR8 EPB41L2 PCNA | 6.71e-08 | 777 | 231 | 21 | 35844135 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 AMER1 INPP4A PARVB TSNAX RXRA CEP170 SERPINB6 AP1S1 GRK3 INTS2 ASTN2 KIF5C ALDH3B2 MCF2L DOCK6 UBR2 CDC42BPA ANK3 STXBP5L CARMIL1 ECPAS SPTBN4 ANKRD24 PATJ EP300 EPB41L1 HTT DOP1A PDZD2 | 6.97e-08 | 1489 | 231 | 30 | 28611215 |
| Pubmed | DOCK4 VCP CDC42BPA ANK2 ANK3 GRIA2 GRIA3 GRIA4 LRRC4C RING1 CTNNA2 | 9.69e-08 | 197 | 231 | 11 | 36604605 | |
| Pubmed | ARHGAP26 MCM2 PLEKHG5 INTS2 TELO2 CCSER2 DOCK6 RAD21 CDC42BPA ZNF507 CACHD1 ECPAS WDR19 LRRC8A HMGXB3 ATP1A2 ZNF646 | 1.13e-07 | 529 | 231 | 17 | 14621295 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RABEP2 ILK PSMB7 PSMC2 MCM2 RPS18 TSNAX TELO2 RAB3GAP2 UGDH TIMELESS VCP GPC1 PPP4R1 AMPD2 HSPA4L NUP98 LAMB2 PTPN23 ECPAS AKAP12 NMI PARVA KIF13A EPB41L1 EPB41L2 PCNA HTT AHNAK2 | 1.47e-07 | 1455 | 231 | 29 | 22863883 |
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 2.33e-07 | 9 | 231 | 4 | 9051806 | |
| Pubmed | 2.89e-07 | 3 | 231 | 3 | 29861105 | ||
| Pubmed | 2.89e-07 | 3 | 231 | 3 | 18163426 | ||
| Pubmed | Human ankyrins and their contribution to disease biology: An update. | 2.89e-07 | 3 | 231 | 3 | 33410423 | |
| Pubmed | 2.89e-07 | 3 | 231 | 3 | 15284246 | ||
| Pubmed | Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue. | 2.89e-07 | 3 | 231 | 3 | 34289389 | |
| Pubmed | ATXN2L AMER1 MATN2 PSMC2 RPS18 RXRA KANK1 TAX1BP1 CLTC UGDH MLLT1 VCP GPC1 RAF1 UBR2 CDC42BPA HSPA4L NUP98 SPECC1L RING1 CHTF18 PATJ CDH1 ATP2A2 AQR PCNA | 2.93e-07 | 1247 | 231 | 26 | 27684187 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYO1G MYH1 MYH4 MYH8 PSMC2 MCM2 TUBA8 RAB3GAP2 TAX1BP1 CLTC UGDH C3 VCP HSPA4L SPECC1L AKAP12 CDH1 ATP2A2 | 3.98e-07 | 647 | 231 | 18 | 26618866 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DOCK4 MYH4 ILK PSMC2 PARVB AP1S1 TELO2 CCDC47 MORF4L1 RAB3GAP2 CLTC GNL2 KIF5C VCP PPP4R1 RAF1 HSPA4L UFC1 NUP98 LCN1 ECPAS METTL13 PARVA GEMIN4 ATP2A2 EPB41L2 | 5.09e-07 | 1284 | 231 | 26 | 17353931 |
| Pubmed | GAK PSMC2 MCM2 CEP170 SERPINB6 CCDC47 MORF4L1 TAX1BP1 CLTC C3 VCP GPC1 PTPN23 APOB SEC31A SYF2 KANK2 AKAP12 RING1 METTL13 MTMR4 CTNNA2 ATP2A2 AQR EPB41L2 PCNA | 6.15e-07 | 1297 | 231 | 26 | 33545068 | |
| Pubmed | ATXN2L AP1S1 RAB3GAP2 ANK2 HSPA4L STXBP5L PCLO NBEA CTNNA2 ATP1A2 ATP2A2 EPB41L1 HTT | 6.71e-07 | 347 | 231 | 13 | 17114649 | |
| Pubmed | GAK PTPN2 PMPCA TELO2 CCDC47 RAB3GAP2 CLTC CCSER2 GNL2 SLC39A6 EIF2AK3 VCP RAD21 CDC42BPA ANK2 ANK3 HSPA4L APBB1 RRP8 KANK2 AKAP12 WDR19 KIRREL1 SMCR8 ATP2A2 EPB41L1 AQR EPB41L2 | 7.63e-07 | 1487 | 231 | 28 | 33957083 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ATXN2L SETD1B DOCK11 INPP4A SMC5 ITIH3 C3 MCF2L VCP RAD21 GPC1 HSPA4L KANSL1 LRRC8A HTT | 8.01e-07 | 475 | 231 | 15 | 31040226 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH1 MYH8 GAK ILK MYLK SLC25A25 LYST CEP170 INTS2 MLLT1 CPLANE1 RAF1 CDC42BPA HSPA4L GRIA2 KANK2 RING1 LIMK2 PARVA PRKCD EP300 | 8.87e-07 | 910 | 231 | 21 | 36736316 |
| Pubmed | DOCK4 DOCK11 ARHGAP26 MCM2 PLEKHG5 CEP170 CCDC47 MCAT MCF2L DOCK6 ARAP2 CDC42BPA HSPA4L NUP98 APBB1 NBEA PRC1 ECPAS PATJ EPB41L2 PCNA | 9.85e-07 | 916 | 231 | 21 | 32203420 | |
| Pubmed | KIF5C ANK2 ANK3 GRIA2 GRIA3 GRIA4 NBEA SPTBN4 CTNNA2 EPB41L1 EPB41L2 | 1.08e-06 | 251 | 231 | 11 | 27507650 | |
| Pubmed | AMER1 ARHGAP26 TSNAX INTS2 CLTC CCSER2 TIMELESS PLD1 CPLANE1 AMPD2 ANK3 ZNF507 CCDC127 PTPN23 APOB SEC31A AKAP12 PRKCD HMGXB3 PATJ RAP2C KIF13A CDH1 | 1.10e-06 | 1084 | 231 | 23 | 11544199 | |
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 28608780 | ||
| Pubmed | AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. | 1.15e-06 | 4 | 231 | 3 | 9221927 | |
| Pubmed | Interaction proteomics reveals brain region-specific AMPA receptor complexes. | 1.15e-06 | 4 | 231 | 3 | 25337787 | |
| Pubmed | Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors. | 1.15e-06 | 4 | 231 | 3 | 17828255 | |
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 1985022 | ||
| Pubmed | AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks. | 1.15e-06 | 4 | 231 | 3 | 12692557 | |
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 14561864 | ||
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 24652293 | ||
| Pubmed | Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. | 1.15e-06 | 4 | 231 | 3 | 10027300 | |
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 1.15e-06 | 4 | 231 | 3 | 11029314 | |
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 12125045 | ||
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 10688364 | ||
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 17409242 | ||
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 1319477 | ||
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 9648857 | ||
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 1.29e-06 | 13 | 231 | 4 | 20859245 | |
| Pubmed | DOCK4 GAK ILK CEP170 MORF4L1 CLTC RAD21 RAF1 UBR2 ANK3 HSPA4L SEC31A SPECC1L ECPAS CTNNA2 CDH1 EPB41L1 | 1.39e-06 | 634 | 231 | 17 | 34591612 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | RABEP2 BDP1 DOCK11 SMC5 RYR3 GNL2 ANK1 ANK3 HSPA4L CARMIL1 NBEA RRP8 ECPAS LCP1 HYDIN | 1.40e-06 | 497 | 231 | 15 | 36774506 |
| Pubmed | RABEP2 PSMC2 PTPN2 PMPCA TELO2 CCDC47 CLTC GNL2 SLC39A6 PPP4R1 UBR2 CDC42BPA ANK3 NUP98 PTPN23 NBEA CACHD1 PTPRT MTMR4 KIRREL1 ATP2A2 EPB41L1 | 2.31e-06 | 1049 | 231 | 22 | 27880917 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GAK ARHGAP26 PSMB7 PSMC2 MCM2 PTPN2 PMPCA TELO2 UGDH C3 VCP RAF1 HSPA4L NUP98 LAMB2 PTPN23 ECPAS LCP1 KANK2 MTMR4 GEMIN4 | 2.58e-06 | 974 | 231 | 21 | 28675297 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PSMB7 PSMC2 SLC25A25 PTPN2 PMPCA TELO2 CCDC47 SUPV3L1 FDX1 RAB3GAP2 CLTC GNL2 EIF2AK3 VCP RAD21 RAF1 HSPA4L PCLO NUP98 APBB1 RRP8 PTAR1 GEMIN4 PRKCD SMCR8 ATP2A2 AHNAK2 | 2.70e-06 | 1496 | 231 | 27 | 32877691 |
| Pubmed | 2.86e-06 | 5 | 231 | 3 | 35688156 | ||
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 2.86e-06 | 5 | 231 | 3 | 12919077 | |
| Pubmed | 2.86e-06 | 5 | 231 | 3 | 33060591 | ||
| Pubmed | 2.86e-06 | 5 | 231 | 3 | 15797551 | ||
| Pubmed | RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. | 2.86e-06 | 5 | 231 | 3 | 1717158 | |
| Pubmed | 2.86e-06 | 5 | 231 | 3 | 16129400 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 2.86e-06 | 5 | 231 | 3 | 3829126 | |
| Pubmed | 2.86e-06 | 5 | 231 | 3 | 6196357 | ||
| Pubmed | 2.86e-06 | 5 | 231 | 3 | 9482932 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ILK PSMC2 MCM2 RPS18 TSNAX CEP170 SERPINB6 CCDC47 MORF4L1 CLTC GNL2 VCP RAD21 AMPD2 HSPA4L CARMIL1 PTPN23 SEC31A CHTF18 PARVA GEMIN4 ATP2A2 AQR EPB41L2 PCNA AHNAK2 | 3.04e-06 | 1415 | 231 | 26 | 28515276 |
| Pubmed | ILK PSMB7 PSMC2 CEP170 SERPINB6 PMPCA CCDC47 SUPV3L1 RAB3GAP2 UGDH MCAT VCP NUP98 SEC31A EPB41L2 | 3.37e-06 | 534 | 231 | 15 | 35032548 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1B ILK PSMC2 MCM2 RPS18 SERPINB6 CCDC47 SUPV3L1 CLTC UGDH VCP GPC1 PTPN23 SEC31A RING1 METTL13 KANSL1 CHTF18 GEMIN4 PRKCD ATP2A2 AQR EPB41L2 PCNA AHNAK2 | 4.33e-06 | 1353 | 231 | 25 | 29467282 |
| Pubmed | ATXN2L ITIH3 CEP170 CCDC47 TAX1BP1 CLTC UGDH GNL2 MCAT PLD1 VCP ZNF574 RAF1 CDC42BPA ANK2 RRP8 APOB SPECC1L RING1 METTL13 GEMIN4 LRRC8A CTNNA2 EPB41L2 PCNA | 5.44e-06 | 1371 | 231 | 25 | 36244648 | |
| Pubmed | PHACTR2 MCM2 SLC39A6 ANK3 CARMIL1 CACHD1 SEC31A ERICH5 AKAP12 CELSR2 KIRREL1 EPB41L1 EPB41L2 | 5.60e-06 | 421 | 231 | 13 | 36976175 | |
| Pubmed | 5.70e-06 | 6 | 231 | 3 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 5.70e-06 | 6 | 231 | 3 | 10077619 | |
| Pubmed | 5.70e-06 | 6 | 231 | 3 | 19009018 | ||
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 5.70e-06 | 6 | 231 | 3 | 23728480 | |
| Pubmed | 5.70e-06 | 6 | 231 | 3 | 16352659 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 5.70e-06 | 6 | 231 | 3 | 10588881 | |
| Pubmed | Functional genomics identifies therapeutic targets for MYC-driven cancer. | 6.01e-06 | 103 | 231 | 7 | 22623531 | |
| Pubmed | 6.40e-06 | 104 | 231 | 7 | 9205841 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ATP13A3 ABCC2 ARAP2 RAF1 CDC42BPA ANK2 CARMIL1 APBB1 APOB CELSR2 PARVA KIRREL1 PATJ EPB41L1 EPB41L2 | 7.20e-06 | 569 | 231 | 15 | 30639242 |
| Pubmed | 8.45e-06 | 20 | 231 | 4 | 32079660 | ||
| Pubmed | 9.93e-06 | 7 | 231 | 3 | 35210422 | ||
| Pubmed | 9.93e-06 | 7 | 231 | 3 | 18499658 | ||
| Pubmed | Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition. | 9.93e-06 | 7 | 231 | 3 | 33981040 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 9.93e-06 | 7 | 231 | 3 | 9016303 | |
| Pubmed | 9.93e-06 | 7 | 231 | 3 | 19798050 | ||
| Pubmed | 9.93e-06 | 7 | 231 | 3 | 27076426 | ||
| Pubmed | Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting. | 9.93e-06 | 7 | 231 | 3 | 11931740 | |
| Pubmed | Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. | 9.93e-06 | 7 | 231 | 3 | 10407040 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 9.93e-06 | 7 | 231 | 3 | 9651535 | |
| Pubmed | 9.93e-06 | 7 | 231 | 3 | 16819597 | ||
| Pubmed | INPP4A PSMC2 RXRA RYR2 KANK1 TAX1BP1 ANK3 CCDC127 LAMB2 LIMK2 MTMR4 KANSL1 SUSD1 ZNF76 KIF13A | 1.13e-05 | 591 | 231 | 15 | 15231748 | |
| Pubmed | 1.39e-05 | 78 | 231 | 6 | 27114451 | ||
| Pubmed | Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea. | 1.58e-05 | 8 | 231 | 3 | 23217150 | |
| Pubmed | Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome. | 1.58e-05 | 8 | 231 | 3 | 20507940 | |
| Pubmed | 1.58e-05 | 8 | 231 | 3 | 3864153 | ||
| Pubmed | 1.58e-05 | 8 | 231 | 3 | 23612611 | ||
| Pubmed | 1.58e-05 | 8 | 231 | 3 | 11784029 | ||
| Pubmed | 1.58e-05 | 8 | 231 | 3 | 36200826 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.58e-05 | 8 | 231 | 3 | 19033399 | |
| Interaction | YWHAH interactions | DOCK4 ATXN2L PHACTR2 AMER1 GPBP1 DOCK11 PSMC2 MCM2 PLEKHG5 LYST CEP170 KANK1 RAB3GAP2 CCSER2 MAP3K15 KIF5C DOCK6 VCP ARAP2 GPC1 RAF1 AMPD2 CDC42BPA CARMIL1 NCKIPSD APBB1 SPECC1L ARFGAP2 MTMR4 PATJ EPB41L1 AQR EPB41L2 HTT DOP1A AHNAK2 | 1.02e-08 | 1102 | 229 | 36 | int:YWHAH |
| Interaction | SFN interactions | ATXN2L GPBP1 DOCK11 MCM2 RPS18 LYST CEP170 PTPN2 CLTC CCSER2 VCP ARAP2 GPC1 CHMP4C RAF1 AMPD2 CDC42BPA CARMIL1 MTMR4 KIF13A CDH1 EPB41L2 HTT DOP1A AHNAK2 | 3.62e-07 | 692 | 229 | 25 | int:SFN |
| Interaction | YWHAG interactions | DOCK4 ATXN2L PHACTR2 AMER1 GPBP1 DOCK11 MCM2 PLEKHG5 LYST CEP170 KANK1 CLTC CCSER2 KIF5C VCP ARAP2 CHMP4C RAF1 AMPD2 CDC42BPA CARMIL1 NCKIPSD APBB1 SPECC1L PRC1 MTMR4 PRKCD PATJ KIF13A EPB41L1 AQR EPB41L2 HTT DOP1A AHNAK2 | 6.71e-07 | 1248 | 229 | 35 | int:YWHAG |
| Interaction | KCNA3 interactions | ATXN2L PSMC2 RPS18 CEP170 CCDC47 RAB3GAP2 EIF2AK3 VCP RAF1 CDC42BPA ANK2 ANK3 HSPA4L CARMIL1 PTPN23 CACHD1 SEC31A SPECC1L ECPAS AKAP12 ARFGAP2 GEMIN4 PATJ SMCR8 ATP2A2 EPB41L1 EPB41L2 DOP1A | 7.27e-07 | 871 | 229 | 28 | int:KCNA3 |
| Interaction | C5AR2 interactions | 2.91e-06 | 78 | 229 | 8 | int:C5AR2 | |
| Interaction | GJA1 interactions | CCDC47 SCN4A CLTC SLC39A6 C3 ATP13A3 EIF2AK3 ARAP2 CDC42BPA ANK3 APBB1 NBEA APOB CACHD1 SEC31A ARFGAP2 KIRREL1 SMCR8 EPB41L1 EPB41L2 HTT | 3.44e-06 | 583 | 229 | 21 | int:GJA1 |
| Interaction | SPTAN1 interactions | GAK PSMB7 CLTC MCAT VCP CHMP4C PPP4R1 RAF1 ANK1 ANK3 GRIA2 APOB PRC1 ECPAS SPTBN4 NMI CDH1 EPB41L2 HTT | 4.27e-06 | 496 | 229 | 19 | int:SPTAN1 |
| Interaction | ITIH3 interactions | 6.46e-06 | 24 | 229 | 5 | int:ITIH3 | |
| Interaction | AP2M1 interactions | ATXN2L GAK AMER1 AP1S1 CLTC ABCC2 VCAM1 VCP RAF1 SPECC1L MTMR4 DGKI KIF13A CDH1 EP300 PCNA HTT | 9.21e-06 | 430 | 229 | 17 | int:AP2M1 |
| Interaction | RAB11A interactions | CCDC47 CLTC SLC39A6 ATP13A3 PLD1 VCP RAF1 CDC42BPA CARMIL1 APBB1 GRIA2 NBEA RRP8 CACHD1 KANK2 AKAP12 MTMR4 PARVA KIRREL1 KIF13A SMCR8 EPB41L1 HTT DOP1A AHNAK2 | 9.25e-06 | 830 | 229 | 25 | int:RAB11A |
| Interaction | RAC1 interactions | DOCK4 ILK DOCK11 PSMC2 CCDC47 CLTC SLC39A6 SNX31 ATP13A3 PLD1 MCF2L DOCK6 VCAM1 VCP ARAP2 RAF1 CDC42BPA ANK3 CARMIL1 GRIA2 AKAP12 PARVA LRRC8A KIRREL1 PRKCD RAP2C ATP2A2 EPB41L1 HTT | 1.14e-05 | 1063 | 229 | 29 | int:RAC1 |
| Interaction | ZFPL1 interactions | CCDC47 SLC39A6 ATP13A3 CDC42BPA ANK3 APBB1 NBEA CACHD1 SEC31A AKAP12 ARFGAP2 MTMR4 KIRREL1 SMCR8 EPB41L1 EPB41L2 AHNAK2 | 1.56e-05 | 448 | 229 | 17 | int:ZFPL1 |
| Interaction | YWHAZ interactions | BDP1 ATXN2L GPBP1 DOCK11 MCM2 SMC5 PLEKHG5 LYST CEP170 KANK1 TAX1BP1 CLTC CCSER2 C3 MAP3K15 KIF5C VCAM1 VCP ARAP2 CHMP4C RAF1 AMPD2 CDC42BPA NCKIPSD KANK2 MTMR4 PRKCD CDH1 ATP2A2 EP300 EPB41L1 EPB41L2 HTT | 1.61e-05 | 1319 | 229 | 33 | int:YWHAZ |
| Interaction | OCLN interactions | PTPN2 CLTC CCSER2 SLC39A6 ARAP2 CDC42BPA ANK2 ANK3 APBB1 NBEA CACHD1 KANK2 AKAP12 KIRREL1 PATJ CDH1 EPB41L1 EPB41L2 | 1.78e-05 | 500 | 229 | 18 | int:OCLN |
| Interaction | MARCKS interactions | CCDC47 RAB3GAP2 TAX1BP1 SLC39A6 ATP13A3 PLD1 VCP RAF1 CDC42BPA ANK2 ANK3 GRIA2 CACHD1 ERICH5 ARFGAP2 KIRREL1 SMCR8 CDH1 EPB41L1 EPB41L2 | 1.88e-05 | 601 | 229 | 20 | int:MARCKS |
| Interaction | HSPB1 interactions | ILK MYLK NEK10 MCM2 GRK3 UGDH VCAM1 VCP PCSK9 RAF1 ANK1 NCKIPSD PRC1 ECPAS LIMK2 KANSL1 GEMIN4 PRKCD ATP2A2 EPB41L1 EPB41L2 HTT | 2.05e-05 | 708 | 229 | 22 | int:HSPB1 |
| Interaction | SEC62 interactions | TMEM74 PTPN2 CCDC47 RAB3GAP2 TAX1BP1 SCN4A SLC39A6 EIF2AK3 RAF1 NUP98 APBB1 GRIA2 CELSR2 PRKCD SMCR8 ATP2A2 EP300 EPB41L2 | 2.08e-05 | 506 | 229 | 18 | int:SEC62 |
| Interaction | H1-1 interactions | SETD1B MCM2 TUBA8 SMC5 KANK1 CRCP PMPCA SCN4A GNL2 ZNF574 PCLO RRP8 LIMK2 DGKI PRKCD UNC13C EP300 HTT | 2.14e-05 | 507 | 229 | 18 | int:H1-1 |
| Interaction | GRIN2B interactions | 2.57e-05 | 170 | 229 | 10 | int:GRIN2B | |
| Interaction | LDHA interactions | PSMB7 PSMC2 MCM2 SMC5 CLTC VCAM1 VCP CHMP4C RAF1 ANK2 AKAP12 CDH1 EP300 PCNA HTT | 2.73e-05 | 375 | 229 | 15 | int:LDHA |
| Interaction | FLOT1 interactions | VCP RAF1 CDC42BPA ANK2 ANK3 PCLO PRC1 ECPAS KANK2 AKAP12 RING1 KIRREL1 PATJ CDH1 EPB41L1 EPB41L2 HTT | 3.29e-05 | 475 | 229 | 17 | int:FLOT1 |
| Interaction | RHOB interactions | PHACTR2 AMER1 DOCK11 CLTC SLC39A6 ATP13A3 PLD1 VCP UBR2 CDC42BPA ANK3 CARMIL1 APBB1 NBEA CACHD1 KANK2 AKAP12 LRRC8A KIRREL1 PRKCD PATJ RAP2C EPB41L1 EPB41L2 | 3.31e-05 | 840 | 229 | 24 | int:RHOB |
| Interaction | SIRT6 interactions | ATXN2L SETD1B GPBP1 DOCK11 MCM2 CEP170 CLTC CCSER2 GNL2 EIF2AK3 RAD21 HSPA4L NUP98 RRP8 PRC1 CELSR2 CHTF18 CDH1 EP300 AQR | 3.50e-05 | 628 | 229 | 20 | int:SIRT6 |
| Interaction | PSMA5 interactions | RABEP2 GAK PSMB7 PSMC2 DDI1 PTPN2 VCAM1 VCP RAF1 AMPD2 APBB1 ECPAS EPB41L1 HTT | 3.59e-05 | 339 | 229 | 14 | int:PSMA5 |
| Interaction | YWHAE interactions | ATXN2L GPBP1 DOCK11 MCM2 TSNAX SMC5 PLEKHG5 LYST CEP170 KANK1 CLTC CCSER2 MAP3K15 VCAM1 VCP ARAP2 GPC1 CHMP4C RAF1 UBR2 AMPD2 CDC42BPA NCKIPSD PRC1 KANK2 MTMR4 NMI CDH1 EPB41L1 EPB41L2 HTT | 3.88e-05 | 1256 | 229 | 31 | int:YWHAE |
| Interaction | PICALM interactions | GAK ILK MCM2 SMC5 CLTC CCSER2 ABCC2 VCAM1 PTPN23 MTMR4 CDH1 HTT | 5.03e-05 | 263 | 229 | 12 | int:PICALM |
| Interaction | MYO6 interactions | ATXN2L GAK PLEKHG5 KANK1 TAX1BP1 CLTC CCSER2 GNL2 VCP RAF1 PTPN23 GEMIN4 KIRREL1 CDH1 HTT | 5.39e-05 | 398 | 229 | 15 | int:MYO6 |
| Interaction | GRIA1 interactions | 5.60e-05 | 86 | 229 | 7 | int:GRIA1 | |
| Interaction | STX6 interactions | GAK TMEM74 CCDC47 CDC42BPA ANK3 CARMIL1 APBB1 PTPN23 NBEA AKAP12 ARFGAP2 KIF13A SMCR8 EPB41L2 HTT AHNAK2 | 5.76e-05 | 448 | 229 | 16 | int:STX6 |
| Interaction | GJD3 interactions | ATP7B PTPN2 CCDC47 RAB3GAP2 SLC39A6 ATP13A3 PLD1 EIF2AK3 VCP CDC42BPA APBB1 CACHD1 SEC31A ARFGAP2 KIRREL1 SMCR8 | 6.74e-05 | 454 | 229 | 16 | int:GJD3 |
| Interaction | RAB4A interactions | RABEP2 GAK ATP7B CCDC47 SLC39A6 ATP13A3 RAF1 APBB1 PTPN23 NBEA CACHD1 KIRREL1 KIF13A SMCR8 HTT AHNAK2 | 7.28e-05 | 457 | 229 | 16 | int:RAB4A |
| Interaction | YWHAQ interactions | ATXN2L PHACTR2 GPBP1 DOCK11 MCM2 SMC5 PLEKHG5 LYST CEP170 KANK1 CLTC CCSER2 KIF5C VCP ARAP2 GPC1 CHMP4C RAF1 AMPD2 CDC42BPA NCKIPSD SPECC1L MTMR4 NMI EPB41L1 EPB41L2 HTT DOP1A | 7.39e-05 | 1118 | 229 | 28 | int:YWHAQ |
| Interaction | PFN1 interactions | DOCK4 MCM2 CLTC MLLT1 VCAM1 VCP CHMP4C RAF1 ANK2 CARMIL1 PCLO NBEA ARFGAP2 KIF13A CDH1 HTT AHNAK2 | 7.72e-05 | 509 | 229 | 17 | int:PFN1 |
| Interaction | DCAF7 interactions | SOX10 CEP170 CLTC TIMELESS VCP ZNF574 PPP4R1 RAF1 NCKIPSD SEC31A RING1 ARFGAP2 EP300 HTT | 8.66e-05 | 368 | 229 | 14 | int:DCAF7 |
| Interaction | RHOF interactions | ILK DOCK11 PARVB TELO2 CCDC47 CLTC SLC39A6 ATP13A3 VCP CDC42BPA ANK3 ECPAS KANK2 AKAP12 LRRC8A KIRREL1 ATP2A2 EPB41L1 PCNA HTT | 9.08e-05 | 673 | 229 | 20 | int:RHOF |
| Interaction | RAC2 interactions | DOCK11 PTPN2 CCDC47 CLTC SLC39A6 ATP13A3 PLD1 EIF2AK3 VCAM1 VCP CDC42BPA CARMIL1 KANK2 AKAP12 PARVA LRRC8A KIRREL1 RAP2C EPB41L1 HTT | 9.27e-05 | 674 | 229 | 20 | int:RAC2 |
| Interaction | YWHAB interactions | DOCK4 ATXN2L DOCK11 MCM2 PLEKHG5 LYST CEP170 KANK1 CLTC CCSER2 KIF5C VCAM1 VCP ARAP2 CHMP4C RAF1 AMPD2 CDC42BPA NCKIPSD MTMR4 PRKCD CDH1 EPB41L1 EPB41L2 HTT AHNAK2 | 9.32e-05 | 1014 | 229 | 26 | int:YWHAB |
| Interaction | AP2A2 interactions | 9.70e-05 | 199 | 229 | 10 | int:AP2A2 | |
| Interaction | NUMA1 interactions | PSMB7 MCM2 TSNAX SMC5 TAX1BP1 VCP RAD21 RAF1 HSPA4L DCAF8L2 DNAH2 NUP98 PRC1 EP300 EPB41L1 EPB41L2 | 9.84e-05 | 469 | 229 | 16 | int:NUMA1 |
| Interaction | LDHB interactions | PSMB7 PSMC2 MCM2 SMC5 VCAM1 VCP CHMP4C PPP4R1 RAF1 UFC1 ECPAS EP300 HTT | 1.00e-04 | 327 | 229 | 13 | int:LDHB |
| Interaction | EMD interactions | ILK MCM2 SMC5 RXRA PTPN2 CCDC47 RAB3GAP2 EIF2AK3 VCAM1 CHMP4C RAF1 ANK1 NUP98 APBB1 GRIA2 SEC31A ARFGAP2 LIMK2 SMCR8 CDH1 ATP2A2 EP300 | 1.02e-04 | 789 | 229 | 22 | int:EMD |
| Interaction | FKBP4 interactions | ILK MYLK MCM2 PTPN2 PMPCA VCAM1 VCP GPC1 CHMP4C RAF1 LIMK2 EPB41L2 | 1.08e-04 | 285 | 229 | 12 | int:FKBP4 |
| Interaction | FERMT3 interactions | 1.23e-04 | 68 | 229 | 6 | int:FERMT3 | |
| Interaction | ARF6 interactions | CCDC47 CLTC SLC39A6 ATP13A3 PLD1 VCP ARAP2 RAF1 CDC42BPA ANK3 APBB1 CACHD1 ECPAS AKAP12 KIRREL1 EPB41L1 EPB41L2 HTT | 1.31e-04 | 584 | 229 | 18 | int:ARF6 |
| Interaction | PSMB1 interactions | GPBP1 PSMB7 PSMC2 MCM2 DDI1 AHSP PTPN2 VCAM1 VCP CHMP4C ECPAS GEMIN4 HTT | 1.31e-04 | 336 | 229 | 13 | int:PSMB1 |
| Interaction | ESCO2 interactions | 1.44e-04 | 70 | 229 | 6 | int:ESCO2 | |
| Interaction | MYO9A interactions | 1.55e-04 | 101 | 229 | 7 | int:MYO9A | |
| Interaction | HSPB8 interactions | 1.60e-04 | 172 | 229 | 9 | int:HSPB8 | |
| Interaction | MESP1 interactions | 1.64e-04 | 10 | 229 | 3 | int:MESP1 | |
| Interaction | PSMB2 interactions | 1.69e-04 | 213 | 229 | 10 | int:PSMB2 | |
| Interaction | RHOQ interactions | ILK DOCK11 CLTC SLC39A6 ATP13A3 PLD1 CDC42BPA CARMIL1 CACHD1 AKAP12 PARVA LRRC8A KIRREL1 SMCR8 EPB41L1 | 1.72e-04 | 442 | 229 | 15 | int:RHOQ |
| Interaction | TMPO interactions | ATXN2L PSMC2 RPS18 SMC5 PTPN2 CCDC47 RAB3GAP2 CLTC UGDH EIF2AK3 VCP RAD21 CHMP4C RAF1 NUP98 APOB PRC1 SMCR8 CDH1 ATP2A2 EP300 | 1.72e-04 | 762 | 229 | 21 | int:TMPO |
| Interaction | ATP6V1D interactions | 1.75e-04 | 103 | 229 | 7 | int:ATP6V1D | |
| Interaction | RIPK4 interactions | ILK PSMC2 CCDC47 CLTC VCP RAF1 ANK2 ANK3 HSPA4L ZNF507 KANK2 AKAP12 WDR19 PRKCD PCNA | 1.90e-04 | 446 | 229 | 15 | int:RIPK4 |
| Interaction | HOMER1 interactions | 2.03e-04 | 140 | 229 | 8 | int:HOMER1 | |
| Interaction | EZR interactions | MYLK MCM2 SLC39A6 KIF5C VCAM1 VCP CDC42BPA ANK2 ANK3 HSPA4L APBB1 NBEA LCP1 KANK2 AKAP12 CDH1 EPB41L1 | 2.08e-04 | 553 | 229 | 17 | int:EZR |
| Interaction | CTTN interactions | ATXN2L MYLK SMC5 UGDH RAD21 GPC1 CHMP4C NCKIPSD GRIA2 SPECC1L PRC1 ARFGAP2 CDH1 EP300 EPB41L2 | 2.09e-04 | 450 | 229 | 15 | int:CTTN |
| Interaction | MCM3 interactions | MCM2 TSNAX SMC5 CLTC TIMELESS VCAM1 VCP RAD21 CHMP4C RAF1 HSPA4L SYF2 EP300 | 2.25e-04 | 355 | 229 | 13 | int:MCM3 |
| Interaction | G3BP1 interactions | ATXN2L PSMC2 MCM2 RPS18 SMC5 PTPN2 GNL2 VCAM1 VCP RAD21 GPC1 CHMP4C RAF1 NUP98 SPECC1L PRC1 KANK2 CTNNA2 ATP2A2 EP300 PCNA HTT | 2.27e-04 | 835 | 229 | 22 | int:G3BP1 |
| Interaction | RHOA interactions | ILK ARHGAP26 PLEKHG5 PTPN2 CCDC47 CLTC SLC39A6 ATP13A3 PLD1 MCF2L EIF2AK3 VCP ARAP2 CDC42BPA ANK3 AKAP12 GEMIN4 LRRC8A KIRREL1 PRKCD CTNNA2 PATJ RAP2C SMCR8 CDH1 ATP2A2 EPB41L1 HTT | 2.38e-04 | 1199 | 229 | 28 | int:RHOA |
| Interaction | CAST interactions | 2.49e-04 | 109 | 229 | 7 | int:CAST | |
| Interaction | KCTD13 interactions | ATXN2L GAK INPP4A ARHGAP26 RPS18 PLEKHG5 CEP170 CLTC MCAT KIF5C VCP GPC1 RAF1 ANK2 ANK3 HSPA4L PPFIA4 CARMIL1 PCLO NCKIPSD GRIA2 NBEA SPECC1L KANK2 SPTBN4 LRRCC1 CTNNA2 ATP2A2 EPB41L1 EPB41L2 PCNA | 2.57e-04 | 1394 | 229 | 31 | int:KCTD13 |
| Interaction | TASOR interactions | 2.63e-04 | 110 | 229 | 7 | int:TASOR | |
| Interaction | H1-5 interactions | GPBP1 RPS18 SMC5 GRK3 SCN4A MLLT1 VCAM1 VCP RAD21 CHMP4C RRP8 PRC1 SSUH2 NMI PRKCD | 2.83e-04 | 463 | 229 | 15 | int:H1-5 |
| Interaction | CHL1 interactions | 2.95e-04 | 12 | 229 | 3 | int:CHL1 | |
| Interaction | EPB41L1 interactions | 2.98e-04 | 187 | 229 | 9 | int:EPB41L1 | |
| Interaction | GAR1 interactions | 3.36e-04 | 232 | 229 | 10 | int:GAR1 | |
| Interaction | RBM25 interactions | ATXN2L ARHGAP26 SMC5 RAB3GAP2 VCP ZNF574 CHMP4C RAF1 PRC1 EP300 EPB41L2 HTT | 3.43e-04 | 323 | 229 | 12 | int:RBM25 |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 2.60e-06 | 4 | 158 | 3 | 1200 | |
| GeneFamily | Parvins | 2.26e-04 | 3 | 158 | 2 | 673 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.26e-04 | 3 | 158 | 2 | 287 | |
| GeneFamily | Myosin heavy chains | 2.76e-04 | 15 | 158 | 3 | 1098 | |
| GeneFamily | Ankyrin repeat domain containing | 2.83e-04 | 242 | 158 | 9 | 403 | |
| GeneFamily | Ankyrin repeat domain containing|KN motif and ankyrin repeat domain containing | 4.50e-04 | 4 | 158 | 2 | 623 | |
| GeneFamily | Erythrocyte membrane protein band 4.1|FERM domain containing | 4.50e-04 | 4 | 158 | 2 | 951 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.25e-03 | 206 | 158 | 7 | 682 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.62e-03 | 9 | 158 | 2 | 1230 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.93e-03 | 161 | 158 | 6 | 593 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | DOCK4 BDP1 TMEM74B RYR2 GRK3 SNX31 KIF5C MCF2L ANK1 ANK2 ANK3 PPFIA4 PCLO GRIA2 GRIA4 GRID2 NBEA SLC4A3 PTPRT KIRREL1 LONRF2 EPB41L1 DOP1A | 7.12e-08 | 703 | 230 | 23 | M39070 |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | PHACTR2 TMEM74B ILK MYLK TESC DOCK6 CDC42BPA LAMB2 KANK2 AKAP12 PARVA ATP1A2 EPB41L1 PLCE1 PDZD2 | 8.58e-08 | 303 | 230 | 15 | M39040 |
| Coexpression | GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN | MYH8 MYLK MCM2 CLTC ABCC2 MCF2L PCSK9 CHMP4C HSPA4L STXBP5L CEACAM20 HTT | 2.01e-07 | 198 | 230 | 12 | M9396 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | ATP7B KANK1 PMPCA GPC1 UBR2 NUP98 LAMB2 METTL13 CELSR2 PRKCD ATP2A2 EP300 AQR | 1.11e-06 | 276 | 230 | 13 | M3063 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | DOCK4 BDP1 TMEM74B INPP4A LYST RYR2 GRK3 KIF5C MCF2L ANK1 ANK2 ANK3 PPFIA4 PCLO GRIA2 GRIA4 GRID2 NBEA SLC4A3 PTPRT CTNNA2 LONRF2 KIF13A HYDIN EPB41L1 DOP1A AHNAK2 | 1.68e-06 | 1106 | 230 | 27 | M39071 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | TMEM74B RYR2 RYR3 PPFIA4 PCLO GRID2 LRRC4C SPTBN4 HYDIN PDZD2 | 2.24e-06 | 166 | 230 | 10 | M39026 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | TMEM74B ILK MYLK ARHGAP26 SERPINB6 KANK1 GRK3 TESC DOCK6 GPC1 LAMB2 KANK2 AKAP12 PARVA KIRREL1 PRKCD ATP1A2 EPB41L1 EPB41L2 PLCE1 PDZD2 | 7.92e-06 | 795 | 230 | 21 | M39050 |
| Coexpression | GSE360_L_MAJOR_VS_T_GONDII_DC_UP | 1.07e-05 | 198 | 230 | 10 | M5207 | |
| Coexpression | VANTVEER_BREAST_CANCER_ESR1_UP | 5.36e-05 | 149 | 230 | 8 | M393 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 RYR2 RYR3 ANO2 ANK1 STXBP5L PCLO APOB LRRC4C HMCN1 UNC13C HYDIN PLCE1 | 1.63e-11 | 184 | 231 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 RYR2 RYR3 ANO2 ANK1 STXBP5L PCLO APOB LRRC4C HMCN1 UNC13C HYDIN PLCE1 | 1.63e-11 | 184 | 231 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 RYR2 RYR3 ANO2 ANK1 STXBP5L PCLO APOB LRRC4C HMCN1 UNC13C HYDIN PLCE1 | 1.63e-11 | 184 | 231 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-08 | 193 | 231 | 10 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-08 | 193 | 231 | 10 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | SOX10 MATN2 GPC1 ANK2 ANK3 AKAP12 HMCN1 ATP1A2 EPB41L2 PLCE1 | 8.72e-08 | 197 | 231 | 10 | b2f4d7c301c0b24003374923b31d6d058e40b213 |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.00e-07 | 200 | 231 | 10 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.00e-07 | 200 | 231 | 10 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | TMEM74B RYR2 DEAF1 ANK2 LRRC4C SLC4A3 PTPRT SPTBN4 ANKRD24 ATP1A2 | 1.00e-07 | 200 | 231 | 10 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-07 | 160 | 231 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-07 | 160 | 231 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-07 | 167 | 231 | 9 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.32e-07 | 184 | 231 | 9 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-07 | 136 | 231 | 8 | 82b1d6d839c0d0c68e0960549f688138479defcc | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.82e-07 | 186 | 231 | 9 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-07 | 187 | 231 | 9 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.66e-07 | 189 | 231 | 9 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.96e-07 | 190 | 231 | 9 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 6.96e-07 | 190 | 231 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.28e-07 | 194 | 231 | 9 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.28e-07 | 194 | 231 | 9 | d429bb5e422a07bd92f0dc48cd51528e8b7d9a72 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.28e-07 | 194 | 231 | 9 | 408dfc7060095972a54ae37ae8105521df6fbbee | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-07 | 194 | 231 | 9 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.28e-07 | 194 | 231 | 9 | bffdf6db0bf3fb338e7bb0789ae7dcde1fce0094 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | PHACTR2 NBPF19 KIF5C ARAP2 STXBP5L PTPRT UNC13C CTNNA2 EPB41L2 | 8.64e-07 | 195 | 231 | 9 | 787e95fb59c40bba784544b662fac37606ae1427 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.02e-07 | 196 | 231 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-07 | 196 | 231 | 9 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-07 | 196 | 231 | 9 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.81e-07 | 146 | 231 | 8 | ec1f793409d1a81c0f9323eb3c82ffe01dae0e44 | |
| ToppCell | erythropoietic-Basophilic_Erythroblast|World / Lineage and Cell class | 9.81e-07 | 198 | 231 | 9 | b3db4db02c0e659163cefb3d83f53e4940cc04bf | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.81e-07 | 198 | 231 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.81e-07 | 198 | 231 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.81e-07 | 198 | 231 | 9 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-06 | 199 | 231 | 9 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.02e-06 | 199 | 231 | 9 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.02e-06 | 199 | 231 | 9 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.07e-06 | 200 | 231 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-06 | 200 | 231 | 9 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.24e-06 | 163 | 231 | 8 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-06 | 164 | 231 | 8 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.46e-06 | 165 | 231 | 8 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.46e-06 | 165 | 231 | 8 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.49e-06 | 116 | 231 | 7 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.57e-06 | 166 | 231 | 8 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-06 | 169 | 231 | 8 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-06 | 169 | 231 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.20e-06 | 171 | 231 | 8 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.49e-06 | 173 | 231 | 8 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-06 | 175 | 231 | 8 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-06 | 180 | 231 | 8 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-06 | 182 | 231 | 8 | c00e503f442d44fbae73c5e2dc85be69e294e67a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-06 | 185 | 231 | 8 | cdd75abdaa1ecedfd2e636203b83a6ac1782f0c3 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-06 | 185 | 231 | 8 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.73e-06 | 185 | 231 | 8 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-06 | 185 | 231 | 8 | 317f2c854f00aa5957319b818c85eeed7d72ec7f | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-06 | 185 | 231 | 8 | 7bb8fdfe04f85d25056380ec58222366de323a21 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 187 | 231 | 8 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 187 | 231 | 8 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 6.20e-06 | 187 | 231 | 8 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.44e-06 | 188 | 231 | 8 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.44e-06 | 188 | 231 | 8 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.70e-06 | 189 | 231 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.96e-06 | 190 | 231 | 8 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.23e-06 | 191 | 231 | 8 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 7.23e-06 | 191 | 231 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.23e-06 | 191 | 231 | 8 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.50e-06 | 137 | 231 | 7 | 0aa4e14b32da0cda677cc0ed6ae470f6ecd77bea | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.81e-06 | 193 | 231 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.81e-06 | 193 | 231 | 8 | a189d46c39067b717509cd144e0225cc93d7731d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-06 | 193 | 231 | 8 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.81e-06 | 193 | 231 | 8 | 0256e8fe4a47f2e2a43ef9d19bfc047d20806d69 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-06 | 193 | 231 | 8 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-06 | 193 | 231 | 8 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-06 | 195 | 231 | 8 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 196 | 231 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 196 | 231 | 8 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.74e-06 | 196 | 231 | 8 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 8.74e-06 | 196 | 231 | 8 | 707eecbb2b14051fd843afa66035014ec59e6bd5 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.74e-06 | 196 | 231 | 8 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 196 | 231 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.74e-06 | 196 | 231 | 8 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.74e-06 | 196 | 231 | 8 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.74e-06 | 196 | 231 | 8 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.07e-06 | 197 | 231 | 8 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | erythropoietic|World / Lineage and Cell class | 9.07e-06 | 197 | 231 | 8 | a52546cebc222050c970e04cec97e4f48ab8fe10 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.07e-06 | 197 | 231 | 8 | ba6393671a980a1d439307601d18db70a1b1e1f3 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-T_reticular|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-06 | 198 | 231 | 8 | 11f21a4a97da10fc6ae604cb627aa3af749d9dff | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.41e-06 | 198 | 231 | 8 | 62059185afdf66126a6fbc899ce611c47e7a0feb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.41e-06 | 198 | 231 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.41e-06 | 198 | 231 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.41e-06 | 198 | 231 | 8 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | LPS_only|World / Treatment groups by lineage, cell group, cell type | 9.76e-06 | 199 | 231 | 8 | 852cf595c2255983cff9045f2bb746d4391cf5ba | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.76e-06 | 199 | 231 | 8 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 9.76e-06 | 199 | 231 | 8 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 9.76e-06 | 199 | 231 | 8 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-05 | 200 | 231 | 8 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.01e-05 | 200 | 231 | 8 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-05 | 200 | 231 | 8 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-05 | 200 | 231 | 8 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-05 | 200 | 231 | 8 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| Drug | 3,5-dihydroxyphenylglycine | 1.51e-07 | 60 | 229 | 8 | CID000108001 | |
| Drug | Ly294486 | 1.21e-06 | 9 | 229 | 4 | CID005311255 | |
| Drug | L-BMAA | 2.05e-06 | 38 | 229 | 6 | CID000028558 | |
| Drug | AC1N9ZZC | 2.81e-06 | 149 | 229 | 10 | CID004369374 | |
| Drug | AC1NSPXR | 3.11e-06 | 11 | 229 | 4 | CID005313815 | |
| Drug | sym 2206 | 3.11e-06 | 11 | 229 | 4 | CID005039877 | |
| Drug | CGP 39653 | 3.58e-06 | 24 | 229 | 5 | CID006437837 | |
| Drug | 3-pyridazinol 1-oxide | 3.99e-06 | 4 | 229 | 3 | CID000574311 | |
| Drug | Atpa | 4.63e-06 | 12 | 229 | 4 | CID000002252 | |
| Drug | 7-chlorokynurenic acid | 5.69e-06 | 45 | 229 | 6 | CID000001884 | |
| Drug | aniracetam | 6.91e-06 | 130 | 229 | 9 | CID000002196 | |
| Drug | AC1NUW3V | 9.61e-06 | 29 | 229 | 5 | CID005462126 | |
| Drug | AC1L1YEG | 9.89e-06 | 5 | 229 | 3 | CID000063114 | |
| Drug | Chicago acid | 9.89e-06 | 5 | 229 | 3 | CID000065740 | |
| Drug | CHEBI:570577 | 9.89e-06 | 5 | 229 | 3 | CID011334126 | |
| Drug | 1-BCP | 9.89e-06 | 5 | 229 | 3 | CID000001370 | |
| Drug | irampanel | 9.89e-06 | 5 | 229 | 3 | CID003038472 | |
| Drug | LY395153 | 9.89e-06 | 5 | 229 | 3 | CID000656707 | |
| Drug | beta-N-oxalylaminoalanine | 9.89e-06 | 5 | 229 | 3 | CID000107978 | |
| Drug | 5-h PCA | 9.89e-06 | 5 | 229 | 3 | CID000129091 | |
| Drug | AC1L32TU | 1.14e-05 | 30 | 229 | 5 | CID000107831 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 1.59e-05 | 32 | 229 | 5 | CID000001222 | |
| Drug | KW-6002 | 1.59e-05 | 32 | 229 | 5 | CID005311037 | |
| Drug | decahydroisoquinoline | 1.65e-05 | 16 | 229 | 4 | CID000097812 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 1.86e-05 | 33 | 229 | 5 | CID000002071 | |
| Drug | QX-314 | 1.90e-05 | 82 | 229 | 7 | CID000003925 | |
| Drug | YM928 | 1.96e-05 | 6 | 229 | 3 | CID006918393 | |
| Drug | 2cmo | 1.96e-05 | 6 | 229 | 3 | CID006914597 | |
| Drug | dibromosulphthalein | 1.96e-05 | 6 | 229 | 3 | CID000086995 | |
| Drug | D-CPPene | 2.16e-05 | 34 | 229 | 5 | CID006435801 | |
| Drug | KN-62 | MYLK RYR3 GRK3 PLD1 EIF2AK3 RAF1 GRIA2 GRIA3 GRIA4 GRIK4 PRKCD | 2.28e-05 | 230 | 229 | 11 | CID000003838 |
| Drug | GYKI 52466 | 2.54e-05 | 58 | 229 | 6 | CID000003538 | |
| Drug | AC1L1KMJ | MYLK TUBA8 GRK3 CLTC VCAM1 RAF1 ANK1 ANK2 ANK3 NCKIPSD LAMB2 LCP1 AKAP12 SPTBN4 PRKCD CDH1 | 2.82e-05 | 476 | 229 | 16 | CID000030956 |
| Drug | R,S)-AMPA | 2.88e-05 | 36 | 229 | 5 | CID000001221 | |
| Drug | C6H12NO5P | 2.88e-05 | 36 | 229 | 5 | CID000104962 | |
| Drug | NS-398; Down 200; 10uM; PC3; HT_HG-U133A | RABEP2 AHSP AP1S1 C3 TIMELESS MCF2L ZNF574 GPC1 CELSR2 ZNF76 | 2.98e-05 | 195 | 229 | 10 | 6892_DN |
| Drug | sodium | RABEP2 IL12B ATP7B RYR2 RYR3 GRK3 SCN4A POLL TESC MCAT ABCC2 ANK2 ANK3 GRIA2 GRIA3 GRIA4 GRID2 GRIK4 SLC4A3 ATP6V0A4 PRKCD ATP1A2 RAP2C ATP2A2 | 3.09e-05 | 944 | 229 | 24 | CID000000923 |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A | INPP4A LYST FAAH MCF2L AMPD2 CDC42BPA ECPAS LCP1 AKAP12 KIF13A | 3.12e-05 | 196 | 229 | 10 | 3187_DN |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 3.26e-05 | 197 | 229 | 10 | 6952_DN | |
| Drug | 4,6-dichloroindole-2-carboxylic acid | 3.41e-05 | 7 | 229 | 3 | CID000127988 | |
| Drug | thio-ATPA | 3.41e-05 | 7 | 229 | 3 | CID005289517 | |
| Drug | LY382884 | 3.43e-05 | 19 | 229 | 4 | CID000656723 | |
| Drug | estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A | TRAF3IP2 RXRA GADD45G ASTN2 POLL DOCK6 APBB1 CELSR2 ZNF76 CDH1 | 3.55e-05 | 199 | 229 | 10 | 5960_DN |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; PC3; HT_HG-U133A | RABEP2 AP1S1 SALL1 ASTN2 ALDH3B2 GRIA3 GRID2 TEX13A ATP1A2 PATJ | 3.55e-05 | 199 | 229 | 10 | 4256_UP |
| Drug | CGS 19755 | 3.77e-05 | 38 | 229 | 5 | CID000068736 | |
| Drug | IDRA 21 | 4.26e-05 | 20 | 229 | 4 | CID000003688 | |
| Drug | HA-966 | 4.29e-05 | 39 | 229 | 5 | CID000001232 | |
| Drug | DETC-MeSO | 4.29e-05 | 39 | 229 | 5 | CID003035711 | |
| Drug | AC1L1B62 | 5.22e-05 | 21 | 229 | 4 | CID000001299 | |
| Drug | AC1L63MU | IL12B LCN1P1 GRK3 PLD1 VCAM1 NCKIPSD GRIA2 GRIA3 GRIA4 GRID2 GRIK4 LCN1 PRKCD | 5.41e-05 | 347 | 229 | 13 | CID000285703 |
| Drug | homoibotenic acid | 5.42e-05 | 8 | 229 | 3 | CID000194385 | |
| Drug | 1-hydroxypyrazole | 5.42e-05 | 8 | 229 | 3 | CID003016733 | |
| Drug | 1-hydroxyimidazole | 5.42e-05 | 8 | 229 | 3 | CID003614351 | |
| Drug | 2,3-PDCA | 5.42e-05 | 8 | 229 | 3 | CID000127037 | |
| Drug | Iem 1460 | 5.42e-05 | 8 | 229 | 3 | CID003248290 | |
| Drug | L000369 | 5.50e-05 | 41 | 229 | 5 | CID003931705 | |
| Drug | bisindolylmaleimide I | 5.55e-05 | 131 | 229 | 8 | ctd:C070515 | |
| Drug | gabapentin | 5.58e-05 | 169 | 229 | 9 | CID000003446 | |
| Drug | NS 102 | 6.32e-05 | 22 | 229 | 4 | CID005282252 | |
| Drug | CX516 | 6.32e-05 | 22 | 229 | 4 | CID000148184 | |
| Drug | Joro spider toxin | 6.95e-05 | 43 | 229 | 5 | CID000119582 | |
| Drug | riluzole | 6.99e-05 | 174 | 229 | 9 | CID000005070 | |
| Drug | YM90K | 7.60e-05 | 23 | 229 | 4 | CID005486547 | |
| Drug | phenobarbital | CYP21A2 RXRA PTPN2 UGDH ABCC2 GRIA2 GRIA3 GRIA4 GRID2 APOB GRIK4 APOL1 PRKCD | 7.84e-05 | 360 | 229 | 13 | CID000004763 |
| Drug | 3,3',4',5-tetrachlorosalicylanilide | 8.07e-05 | 9 | 229 | 3 | CID000014385 | |
| Drug | 1m5b | 8.07e-05 | 9 | 229 | 3 | CID000447081 | |
| Drug | isothiazol-3-one | 8.07e-05 | 9 | 229 | 3 | CID000096917 | |
| Drug | 3-doxylandrostanol | 8.07e-05 | 9 | 229 | 3 | CID000189075 | |
| Drug | LY339434 | 8.07e-05 | 9 | 229 | 3 | CID006324635 | |
| Drug | 1di9 | 8.07e-05 | 9 | 229 | 3 | CID000001714 | |
| Drug | cyclothiazide | 8.30e-05 | 103 | 229 | 7 | CID000002910 | |
| Drug | bromfenacoum | ATXN2L PHACTR2 INPP4A PSMC2 SLC25A25 PMPCA KIF5C ANK3 HSPA4L STXBP5L NUP98 APBB1 LAMB2 GRIA4 ARFGAP2 PATJ ATP2A2 EPB41L1 | 9.81e-05 | 644 | 229 | 18 | ctd:C013418 |
| Drug | Ns102 | 1.07e-04 | 25 | 229 | 4 | CID005311098 | |
| Drug | gavestinel | 1.07e-04 | 25 | 229 | 4 | CID006450546 | |
| Drug | AC1L1DME | 1.09e-04 | 75 | 229 | 6 | CID000002414 | |
| Drug | kynurenine | 1.12e-04 | 108 | 229 | 7 | CID000000846 | |
| Drug | Benzoates | 1.14e-04 | 10 | 229 | 3 | ctd:D001565 | |
| Drug | 2-amino-3-phosphonopropionic acid | 1.18e-04 | 76 | 229 | 6 | CID000003857 | |
| Drug | ODAP | 1.19e-04 | 48 | 229 | 5 | CID000002360 | |
| Drug | avermectin | 1.19e-04 | 48 | 229 | 5 | CID006450460 | |
| Drug | methylenecyclopropylglycine | 1.31e-04 | 49 | 229 | 5 | CID000441452 | |
| Drug | AC1L1GTT | 1.32e-04 | 233 | 229 | 10 | CID000003837 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 1.32e-04 | 233 | 229 | 10 | CID000005114 | |
| Drug | AC1L1FA8 | 1.44e-04 | 50 | 229 | 5 | CID000003150 | |
| Drug | Tunic | 1.46e-04 | 27 | 229 | 4 | CID000004690 | |
| Drug | L-689,560 | 1.46e-04 | 27 | 229 | 4 | CID000121918 | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HG-U133A | 1.48e-04 | 192 | 229 | 9 | 611_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | 1.54e-04 | 193 | 229 | 9 | 4338_DN | |
| Drug | 26-nor-25-doxylcholestanol | 1.56e-04 | 11 | 229 | 3 | CID000125890 | |
| Drug | J-ST | 1.56e-04 | 11 | 229 | 3 | CID005288655 | |
| Drug | YM872 | 1.56e-04 | 11 | 229 | 3 | CID000148200 | |
| Drug | 0-ol | 1.56e-04 | 11 | 229 | 3 | CID000069892 | |
| Drug | Pilocarpine | IL12B ILK ABCC2 EIF2AK3 ANK3 GRIA2 GRIA3 PRKCD CDH1 ATP2A2 PCNA | 1.57e-04 | 285 | 229 | 11 | ctd:D010862 |
| Drug | HU-211 | 1.57e-04 | 114 | 229 | 7 | CID000107778 | |
| Drug | LY354740 | 1.59e-04 | 51 | 229 | 5 | CID000114827 | |
| Drug | Rp-cAMPS | 1.60e-04 | 194 | 229 | 9 | CID006426631 | |
| Drug | Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; MCF7; HT_HG-U133A | RABEP2 SERPINI2 POLL PLD1 ALDH3B2 GRIA3 TRIM68 ATP6V0A4 KIF13A | 1.60e-04 | 194 | 229 | 9 | 5609_UP |
| Drug | NSC3260 | 1.66e-04 | 195 | 229 | 9 | CID000220461 | |
| Drug | C-PP | 1.69e-04 | 28 | 229 | 4 | CID000001228 | |
| Drug | aptiganel | 1.69e-04 | 28 | 229 | 4 | CID000060839 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 1.81e-06 | 49 | 222 | 6 | EFO_0021897 | |
| Disease | response to statin, LDL cholesterol change measurement | 3.99e-06 | 15 | 222 | 4 | EFO_0007804, GO_0036273 | |
| Disease | central nervous system disease (implicated_via_orthology) | 5.29e-06 | 16 | 222 | 4 | DOID:331 (implicated_via_orthology) | |
| Disease | choline measurement | 6.69e-06 | 130 | 222 | 8 | EFO_0010116 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 1.08e-05 | 39 | 222 | 5 | EFO_0022332 | |
| Disease | obsolete_red blood cell distribution width | SETD1B CYP21A2 PSMB7 MCM2 PARVB PLEKHG5 CEP170 PMPCA MORF4L1 GTF2IRD2 SNX31 PLD1 DOCK6 ANK1 CARMIL1 APOB PRC1 LCP1 KANK2 GTF2IRD2B LIMK2 KANSL1 SUSD1 SMCR8 CDH1 EP300 | 1.11e-05 | 1347 | 222 | 26 | EFO_0005192 |
| Disease | LDL cholesterol change measurement | 1.44e-05 | 7 | 222 | 3 | EFO_0007804 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.49e-05 | 145 | 222 | 8 | DOID:1289 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.23e-05 | 200 | 222 | 9 | EFO_0004611, EFO_0020945 | |
| Disease | parental longevity | CYP21A2 MCM2 PARVB RYR3 CCSER2 ANK2 PCLO LAMB2 LRRC4C LCP1 CELSR2 SUSD1 CDH1 HTT | 2.54e-05 | 494 | 222 | 14 | EFO_0007796 |
| Disease | phospholipids in medium VLDL measurement | 4.49e-05 | 52 | 222 | 5 | EFO_0022154 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 4.85e-05 | 10 | 222 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 4.85e-05 | 10 | 222 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 4.85e-05 | 10 | 222 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 4.85e-05 | 10 | 222 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 4.85e-05 | 10 | 222 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 4.85e-05 | 10 | 222 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 4.85e-05 | 10 | 222 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 4.85e-05 | 10 | 222 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | INHBC GADD45G PMPCA DOCK6 PCSK9 CARMIL1 APOB LCP1 CELSR2 CEACAM20 | 5.00e-05 | 276 | 222 | 10 | EFO_0004612, EFO_0020943 |
| Disease | docosahexaenoic acid measurement | 5.16e-05 | 127 | 222 | 7 | EFO_0007761 | |
| Disease | hypobetalipoproteinemia (is_implicated_in) | 5.64e-05 | 2 | 222 | 2 | DOID:1390 (is_implicated_in) | |
| Disease | Bipolar Disorder | TSNAX TUBA8 ITIH3 GRK3 ASTN2 TIMELESS ANK3 PCLO GRIA2 GRIA3 GRIK4 ATP1A2 DKK4 | 7.35e-05 | 477 | 222 | 13 | C0005586 |
| Disease | myocardial infarction | ARHGAP26 MORF4L1 PCSK9 NCKIPSD LAMB2 APOB LCP1 CELSR2 ATP2A2 HTT PDZD2 | 7.61e-05 | 350 | 222 | 11 | EFO_0000612 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | INHBC CYP21A2 PMPCA DOCK6 PCSK9 APOB LCP1 CELSR2 CEACAM20 HTT | 7.77e-05 | 291 | 222 | 10 | EFO_0008317, EFO_0020946 |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 7.95e-05 | 94 | 222 | 6 | EFO_0008595, EFO_0010351 | |
| Disease | myotonia congenita (implicated_via_orthology) | 8.79e-05 | 12 | 222 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 8.79e-05 | 12 | 222 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 8.88e-05 | 239 | 222 | 9 | EFO_0008317, EFO_0020945 | |
| Disease | phospholipids in small VLDL measurement | 8.99e-05 | 60 | 222 | 5 | EFO_0022146 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.01e-04 | 243 | 222 | 9 | EFO_0004612, EFO_0020944 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 1.06e-04 | 99 | 222 | 6 | DOID:11446 (biomarker_via_orthology) | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.14e-04 | 63 | 222 | 5 | EFO_0001645, EFO_0004792 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.14e-04 | 13 | 222 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | INHBC GADD45G PMPCA DOCK6 PCSK9 APOB LCP1 KANSL1 CELSR2 CEACAM20 | 1.21e-04 | 307 | 222 | 10 | EFO_0004612, EFO_0020946 |
| Disease | uterine fibroid | 1.40e-04 | 199 | 222 | 8 | EFO_0000731 | |
| Disease | Grand Mal Status Epilepticus | 1.52e-04 | 67 | 222 | 5 | C0311335 | |
| Disease | Petit mal status | 1.52e-04 | 67 | 222 | 5 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 1.52e-04 | 67 | 222 | 5 | C0393734 | |
| Disease | Status Epilepticus, Subclinical | 1.52e-04 | 67 | 222 | 5 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 1.52e-04 | 67 | 222 | 5 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 1.52e-04 | 67 | 222 | 5 | C0751523 | |
| Disease | Intellectual Disability | INPP4A PTCHD1 CCDC47 DEAF1 PTPN23 GRIA2 NBEA SPECC1L KANSL1 CTNNA2 EPB41L1 HTT | 1.60e-04 | 447 | 222 | 12 | C3714756 |
| Disease | Status Epilepticus | 1.63e-04 | 68 | 222 | 5 | C0038220 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.68e-04 | 3 | 222 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.68e-04 | 3 | 222 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 1.70e-04 | 37 | 222 | 4 | EFO_0022281 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.79e-04 | 15 | 222 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Malignant mesothelioma | 1.80e-04 | 109 | 222 | 6 | C0345967 | |
| Disease | coronary artery disease, factor VII measurement | 1.99e-04 | 111 | 222 | 6 | EFO_0001645, EFO_0004619 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 2.00e-04 | 71 | 222 | 5 | EFO_0001645, EFO_0004791 | |
| Disease | Hypercholesterolemia | 2.09e-04 | 39 | 222 | 4 | C0020443 | |
| Disease | Schizoaffective disorder-bipolar type | 2.19e-04 | 16 | 222 | 3 | EFO_0009965 | |
| Disease | factor VIII measurement, coronary artery disease | 2.19e-04 | 113 | 222 | 6 | EFO_0001645, EFO_0004630 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 2.77e-04 | 118 | 222 | 6 | EFO_0010119 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.77e-04 | 118 | 222 | 6 | EFO_0001645, EFO_0004629 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 3.06e-04 | 43 | 222 | 4 | EFO_0022290 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 3.15e-04 | 18 | 222 | 3 | EFO_0008317, EFO_0008589 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.17e-04 | 121 | 222 | 6 | EFO_0008595, EFO_0020943 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 3.17e-04 | 121 | 222 | 6 | EFO_0004612, EFO_0005271 | |
| Disease | concentration of large LDL particles measurement | 3.34e-04 | 44 | 222 | 4 | EFO_0022160 | |
| Disease | cholesterol in medium VLDL measurement | 3.34e-04 | 44 | 222 | 4 | EFO_0022225 | |
| Disease | Hypokalemic periodic paralysis | 3.35e-04 | 4 | 222 | 2 | C0238358 | |
| Disease | total lipids in very small VLDL measurement | 3.65e-04 | 45 | 222 | 4 | EFO_0022156 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 3.65e-04 | 45 | 222 | 4 | EFO_0022236 | |
| Disease | angina pectoris | 3.78e-04 | 125 | 222 | 6 | EFO_0003913 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 3.94e-04 | 126 | 222 | 6 | EFO_0004611, EFO_0010351 | |
| Disease | esterified cholesterol measurement | 4.29e-04 | 128 | 222 | 6 | EFO_0008589 | |
| Disease | free cholesterol in small VLDL measurement | 4.32e-04 | 47 | 222 | 4 | EFO_0022272 | |
| Disease | free cholesterol in very small VLDL measurement | 4.32e-04 | 47 | 222 | 4 | EFO_0022275 | |
| Disease | free cholesterol in medium VLDL measurement | 4.32e-04 | 47 | 222 | 4 | EFO_0022269 | |
| Disease | total lipids in lipoprotein particles measurement | 4.68e-04 | 48 | 222 | 4 | EFO_0022309 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.89e-04 | 86 | 222 | 5 | EFO_0008595, EFO_0020945 | |
| Disease | cerebellar cortex volume measurement | 5.06e-04 | 21 | 222 | 3 | EFO_0010291 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 5.06e-04 | 21 | 222 | 3 | EFO_0022246 | |
| Disease | cholesterol in medium LDL measurement | 5.07e-04 | 49 | 222 | 4 | EFO_0022224 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 5.07e-04 | 49 | 222 | 4 | EFO_0022256 | |
| Disease | Malignant neoplasm of breast | MYH1 ATP7B FAAH TAX1BP1 SLC39A6 ASTN2 TIMELESS GPC1 RAF1 ANK1 ANK2 NUP98 APOL1 PRC1 AKAP12 CDH1 EP300 DOP1A ZNF646 | 5.26e-04 | 1074 | 222 | 19 | C0006142 |
| Disease | triglycerides to total lipids in medium LDL percentage | 5.48e-04 | 50 | 222 | 4 | EFO_0022334 | |
| Disease | free cholesterol in LDL measurement | 5.48e-04 | 50 | 222 | 4 | EFO_0022266 | |
| Disease | odorant-binding protein 2b measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0801859 | |
| Disease | hemojuvelin measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0008148 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 5.82e-04 | 22 | 222 | 3 | EFO_0009312 | |
| Disease | free cholesterol in large LDL measurement | 5.91e-04 | 51 | 222 | 4 | EFO_0022176 | |
| Disease | triglycerides to total lipids in large LDL percentage | 5.91e-04 | 51 | 222 | 4 | EFO_0022331 | |
| Disease | phospholipids in very small VLDL measurement | 5.91e-04 | 51 | 222 | 4 | EFO_0022300 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 6.34e-04 | 91 | 222 | 5 | EFO_0004611, EFO_0005271 | |
| Disease | total lipids in medium LDL | 6.36e-04 | 52 | 222 | 4 | EFO_0022180 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 6.84e-04 | 53 | 222 | 4 | EFO_0022340 | |
| Disease | cholesterol in small VLDL measurement | 6.84e-04 | 53 | 222 | 4 | EFO_0022228 | |
| Disease | free cholesterol in small LDL measurement | 6.84e-04 | 53 | 222 | 4 | EFO_0022271 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 6.84e-04 | 53 | 222 | 4 | EFO_0022258 | |
| Disease | total lipids in medium VLDL | 7.35e-04 | 54 | 222 | 4 | EFO_0022153 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 7.35e-04 | 54 | 222 | 4 | EFO_0022244 | |
| Disease | Stuttering | 7.69e-04 | 143 | 222 | 6 | HP_0025268 | |
| Disease | myeloid white cell count | MYO1G SETD1B ARHGAP26 CYP21A2 PSMB7 CRCP PMPCA SUPV3L1 C3 VCAM1 UBR2 CDC42BPA RWDD3 KIRREL1 ATP2A2 HTT PLCE1 | 7.84e-04 | 937 | 222 | 17 | EFO_0007988 |
| Disease | triglycerides in medium VLDL measurement | 7.87e-04 | 55 | 222 | 4 | EFO_0022155 | |
| Disease | phospholipids in medium HDL measurement | 7.87e-04 | 55 | 222 | 4 | EFO_0022295 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 7.98e-04 | 144 | 222 | 6 | EFO_0004611, EFO_0020943 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 8.08e-04 | 96 | 222 | 5 | EFO_0004529, EFO_0008595 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FTVVQGEMRVPEEAL | 96 | Q5SW79 | |
| PEVFRTRIEAATQME | 406 | Q8WVB6 | |
| SEVFEQEIDPVMQSL | 1146 | Q09472 | |
| ETMIVSDQIRPEDRA | 401 | P48751 | |
| LRMETTERENPEAET | 666 | A6H8Y1 | |
| QEEARLVEEAQTPVM | 51 | Q5SNV9 | |
| EIDRMTLTVNVELPD | 401 | P35626 | |
| TVTVNVEDVQDMAPV | 231 | Q96JP9 | |
| QDRESMETVPFTVES | 166 | Q9NZJ5 | |
| VFNDPLVSEEDMVTV | 26 | Q9NZD4 | |
| SPVEREMVVQVEREK | 1331 | Q02952 | |
| EMVVQVEREKTEAEP | 1336 | Q02952 | |
| DNMTVRVPETVADAR | 161 | P10109 | |
| TEEETALHNRIMPTV | 576 | Q9H7F0 | |
| SVISPEELRAAIEDM | 406 | P35670 | |
| MPETVVIRSEEQEQA | 866 | P16157 | |
| PDQVHITRESASEMI | 346 | Q6UY09 | |
| LQEEDESPRSVLEEM | 141 | P61966 | |
| MARQPEEEETAVARA | 1 | Q5VU97 | |
| PVAQMTEDAVDAERL | 986 | P01024 | |
| STLDINEMVRTERPD | 1086 | Q69YQ0 | |
| PGAMETEEERLVTIQ | 551 | Q5JTC6 | |
| VLEHRVMTIPEENET | 1591 | Q5JWR5 | |
| APEVTLQADIEVMST | 276 | O75952 | |
| VTLTLAEEASQEPEM | 91 | O00213 | |
| LSEMQVIEQETPVSA | 321 | Q8N6H7 | |
| RISPVMEAEELTNDI | 1346 | Q8WZ64 | |
| MEEAAQILEIETFIP | 1061 | O60306 | |
| RNPEVVTVEMKEDQE | 381 | Q8IYA2 | |
| ARTPMEVTVTVLDVN | 901 | Q9HCU4 | |
| VDVQETEPVMQEEIF | 241 | P48448 | |
| QAVQSEMLETIPEEA | 856 | Q01433 | |
| TIEEDIPSREMCDQQ | 391 | Q9NQ90 | |
| DETQMEVEALAEVIP | 471 | Q8TF21 | |
| SPQEALVRLRETEEM | 21 | Q96CF2 | |
| LVTEDPADVREEAML | 621 | O75129 | |
| REDIVDTMVFKPSDV | 176 | Q8WWM7 | |
| ELQPTEVESRDLMSS | 296 | Q8IWF9 | |
| RMPREEATEIEQTVQ | 386 | Q9UGP5 | |
| VSTTLPVDSRMIEDA | 266 | P04049 | |
| NKVDLEPEREVMSSE | 116 | Q9Y3L5 | |
| EEPSRLQESVMEASR | 446 | O60216 | |
| ETLEQVRSIMDEAPL | 546 | Q9H5N1 | |
| PDTVQDALRFTMDVI | 291 | Q9H3S7 | |
| MPTTIEREFEELDTQ | 1 | P17706 | |
| PLEIEVLEETVQTMD | 261 | Q99436 | |
| SVDTVNGRMVLPVDE | 186 | Q96PE3 | |
| VSEDVEATVPMLQRT | 201 | Q8IWT6 | |
| CVVRDTVDPVQDEML | 661 | P49736 | |
| TVDPVQDEMLARFVV | 666 | P49736 | |
| RARVDPTVENEETFM | 176 | Q9UBU8 | |
| PTVENEETFMNRVEV | 181 | Q9UBU8 | |
| LRDSAVMDDSVVIPS | 916 | Q01484 | |
| MEADVSRDEIQVPVL | 1111 | Q9H2M9 | |
| AESRVPVEEIQIIHM | 36 | Q8WTU0 | |
| IEPEAVLQTRVSAMD | 711 | Q9H4G0 | |
| VDITQEPVLDTMLEE | 951 | P52948 | |
| TLQVERLAVMEVAPS | 501 | Q15746 | |
| SSDVVVQVLDARDPM | 216 | Q13823 | |
| MIVTDGRPQDSVAEV | 166 | O00339 | |
| APVLSDDELVSMSVR | 21 | O60675 | |
| SLMVEASPLTIEDER | 716 | Q9NPP4 | |
| IVLMRAAEEPVSEVT | 71 | Q05655 | |
| PLTEDEMREFQVISE | 406 | Q86WP2 | |
| EVEVDITKPDMTIRQ | 441 | P35052 | |
| NEVVLAPMFERLSTE | 126 | P53671 | |
| DRDSNIVKTDIPDMV | 331 | P55103 | |
| QTMRKAETLPEVEAE | 356 | O75335 | |
| VRPQEVSETEPSRDM | 1171 | Q96MR6 | |
| ETSEEEVQDRVQCMP | 616 | P0C7V8 | |
| MEDSVTESPQRVIIT | 46 | Q96A33 | |
| IRDSMEPVVEQLTQE | 131 | P08686 | |
| VEMQPTELVSKEREE | 161 | O43491 | |
| EEPETRLAIQEALSM | 451 | Q5VYK3 | |
| METEVIEQVAFPASI | 931 | Q12766 | |
| SKVVPEAELQEETMR | 221 | Q96DC8 | |
| TVERMVSPIESAEDL | 646 | P42262 | |
| LTVERMVSPIESAED | 656 | P42263 | |
| LTVERMVSPIESAED | 646 | P48058 | |
| VTVLEEPFVMVSENV | 446 | O43424 | |
| TVDRELPEMNLESVT | 41 | Q5VSP4 | |
| ITVPSIDDQEELMAT | 321 | P13535 | |
| ASPTEELRQAAEMEE | 1836 | Q9Y6V0 | |
| EEEAVTIEMNEPVQL | 191 | P12004 | |
| IEGRVMVTDFENVPE | 196 | Q8NBP7 | |
| MINLSVPDTIDERTI | 166 | P13796 | |
| EARPDIVEVSSMISD | 771 | Q6ZWH5 | |
| PKVSEQEMDEVIARS | 816 | O15018 | |
| STRIVEEADVDMEPN | 356 | Q9H0H0 | |
| SQVEAAVMAVPRTAD | 656 | Q14678 | |
| LDDVGAVPMVERVTA | 751 | Q7Z3B3 | |
| TVDREFPEMNLESVT | 41 | P31025 | |
| MEGTVESQTPDLRDV | 1 | Q96LR2 | |
| EGADPDSIEMVATRV | 1526 | P55268 | |
| VEEIPEDAASITMRR | 891 | Q92887 | |
| TVTVETMEPSQDEAR | 456 | Q9HCJ2 | |
| ITVPSIDDQEELMAT | 321 | P12882 | |
| EEMSELSNLTRDVPI | 526 | Q1L5Z9 | |
| HMIPIGEESTREENV | 101 | O75167 | |
| AAEESLPIEVMVDAV | 201 | P29460 | |
| DSVINVPLRMIDSVE | 66 | Q9NYA4 | |
| MVDEEQTVPFALRDE | 5571 | Q96RW7 | |
| NPEGRMESEELVVQT | 466 | O14522 | |
| QLEENEERTMIDPTS | 66 | Q9HBI1 | |
| KIRAEAMQEASEAVP | 176 | Q8IVS2 | |
| IEDSNRTRITPEEMS | 421 | Q9H7U1 | |
| VDVPENTVILDEMTL | 651 | Q9H7U1 | |
| RALVEEEITRNTTPM | 211 | O14976 | |
| EMRDAVEKPQEFTIV | 2041 | P04114 | |
| RDEMVATEQERTPLQ | 236 | P16615 | |
| ETVEDIAARLNIPMS | 636 | P50993 | |
| SPEQVRAMERTVENI | 1016 | Q8NFZ0 | |
| PDSESVIVAMERVSV | 2946 | P42858 | |
| VVTEEEVNRMLTPSE | 36 | Q4G0P3 | |
| MATESTPSEIIERER | 1 | Q9BX69 | |
| QNITVEVEEFVPEMT | 616 | Q5JSL3 | |
| REVVEMSPLENAIEV | 1461 | Q8N1I0 | |
| ETVLTPVEVAIEDMQ | 1896 | Q96HP0 | |
| LLSETVMPRFAEQVE | 576 | P26232 | |
| VMPRFAEQVEVAIEA | 581 | P26232 | |
| AVLMIRTPEELEDDS | 626 | P26232 | |
| QVAEPRVRDVINSME | 251 | Q8NEX9 | |
| LVRASVDPVAADLEM | 191 | Q96BQ5 | |
| VQCQREEPLETIMEE | 1946 | Q9H799 | |
| TTMEDATPILERQLD | 91 | Q9UBT3 | |
| AERETPRVTAVAVMA | 56 | O75398 | |
| SQDEIFILDPDMVVS | 846 | O75912 | |
| MTLEEVRGQDTVPES | 1 | O95257 | |
| VPVESQMEELTTRLA | 651 | Q8IYE1 | |
| VTREVPFADLSNMEI | 386 | Q13418 | |
| RNPEVVTVEMKEDQE | 431 | Q3MJ40 | |
| TTVEETAVEREMPND | 3221 | Q12955 | |
| EQVERVNEPSILEMS | 316 | O14791 | |
| MDVSAVEDPVQRRAL | 3386 | Q99698 | |
| VIRLVQDTPEATAMA | 41 | O15068 | |
| NTEEEIRMELSPDLI | 581 | Q63ZY3 | |
| ETVNREPLTMHSDRE | 541 | Q96J84 | |
| ESMAGEVTRVVDEQL | 761 | Q5VZK9 | |
| VVPVTTVTAEDEAQM | 506 | O00519 | |
| VVISPQVSREDMDFL | 496 | Q6ZQY3 | |
| PLRSMVEDLQSEESD | 401 | Q03111 | |
| EAPLTVESDMNTVVR | 381 | P54792 | |
| DAVEIDPSMLEVATQ | 521 | Q8N6R0 | |
| VQRMDVPIESVDDLA | 646 | Q16099 | |
| RAVEVTENPQTAAEM | 171 | Q6P6B1 | |
| MAQVAVSTLPVEEES | 1 | Q86UP8 | |
| MAQVAVSTLPVEEES | 1 | Q6EKJ0 | |
| IAMPEQVSLLFEVED | 2196 | Q9P225 | |
| REESMEVEAPVANKS | 121 | Q9NSC2 | |
| ESTSSANEDMPVERI | 221 | P19793 | |
| QESVIEDPELVRAMF | 2071 | Q92736 | |
| TNLERDMLPDEVTEE | 116 | Q99445 | |
| VMEIVVRLSEDAEPT | 86 | Q9P1A2 | |
| QEAIMDGTEIAVSPR | 26 | Q06587 | |
| AVEDPMEILITVTDQ | 241 | P12830 | |
| LDVNDNVPEVMVTSL | 341 | Q9UN75 | |
| EVMRVTGAVPERVVE | 826 | Q9H1H9 | |
| DVAVVDMSDVSRQPS | 121 | Q6ZN16 | |
| SDQVAPTDIEEGMRV | 126 | P35998 | |
| VLQPRLTDEEVEMTR | 171 | Q10713 | |
| IDEMDSVPTVRQAVK | 201 | P19320 | |
| RASSPVEELLTMEDE | 121 | Q86VP1 | |
| PVTAVEIQLMVEESE | 91 | O75575 | |
| THVPSTEEIDRMVID | 171 | O95926 | |
| DDSEPTVRAELMEQV | 96 | Q8TF05 | |
| TIQVPIASEESDLEM | 921 | P35499 | |
| MAETSEEVAVLVQRV | 1 | Q7Z6K3 | |
| ERFVSSPEEVMDVID | 171 | O60282 | |
| MEVEEPEVLQDSLDR | 596 | Q8N660 | |
| SVLMEVEEPEVLQDS | 3766 | A0A087WUL8 | |
| EMAVIVQDTETVPSV | 926 | Q13393 | |
| FPEEVASILMEQEQT | 531 | Q9P212 | |
| VEMVDIDSTRVVDQI | 871 | Q96NR3 | |
| MVVTKPEDNEDERAI | 601 | Q06033 | |
| SITDPVLREAMEAQI | 2531 | Q8NFP9 | |
| QIPEEEREAVATIMS | 251 | O43663 | |
| FDVEAVDRPGVITMQ | 336 | Q9UNA1 | |
| VDRPGVITMQALSEE | 341 | Q9UNA1 | |
| PEDVESIRDILTSNM | 586 | Q6AI14 | |
| IIMLPDETTDLRTVE | 231 | P35237 | |
| VEQVPDRAMEAVLTG | 256 | Q9Y4R8 | |
| SLAMSSNRPVEIVED | 56 | Q9UPS6 | |
| ITVPSIDDQEELMAT | 321 | Q9Y623 | |
| GMVRRPDISEIEEAT | 1236 | Q8NEZ3 | |
| EVAVIDEIQMIRDPA | 286 | Q8IYB8 | |
| EELPRAFVNVVEVME | 1241 | Q6P1J6 | |
| EENEVRTMVDPNSRS | 76 | Q9NVD7 | |
| PSVVISQVIDMRDEE | 1126 | Q5VT25 | |
| TFAVRMPEEVVNAVE | 291 | Q96B86 | |
| SVLPVELARDMQTDT | 481 | Q9NZQ3 | |
| VTMDPNVLRSDVFVE | 86 | Q8N9S9 | |
| CMEISLPVTTEENRE | 796 | Q9Y2K9 | |
| SQQPAVLEEEEVMIA | 506 | Q13433 | |
| VEVDDRMVEKQESIP | 376 | Q8TEV9 | |
| VPAMTEEVAREALLS | 71 | Q9Y2M2 | |
| MSRPEAVQEATEVTL | 101 | Q8IVF2 | |
| EVAVSLPSVEVDMQA | 1286 | Q8IVF2 | |
| DVEVSLPSMEVDVQA | 1946 | Q8IVF2 | |
| DVEVSLPSMEVDVQA | 2111 | Q8IVF2 | |
| QETRMNRSIPVEVDE | 6 | O43734 | |
| EPLADITQIVDVFME | 541 | Q00610 | |
| RPIDTTMDEEQVELS | 96 | Q96BS2 | |
| TVPDEFTVEERQTGM | 171 | Q6KCM7 | |
| FDLNVDIETEIVPAM | 81 | O94827 | |
| AASEVPVEEQRAEAM | 586 | Q9UNS1 | |
| MCPEIRVTVVDVNES | 26 | O60701 | |
| MAEPVQEELSVLAAI | 1 | Q9Y3V2 | |
| MADEATRRVVSEIPV | 1 | Q9Y3C8 | |
| EARVNPDTVTAREME | 146 | Q9NUR3 | |
| MDPTALVEAIVEEVA | 1 | Q6AZZ1 | |
| EPMTLQEREDVTASA | 866 | Q9UPR6 | |
| EPLNETSAEMEIRED | 936 | Q8NB66 | |
| ITTISDPMEEDILQV | 1176 | Q9UBZ9 | |
| RERQTNPSAMEVEED | 711 | P55072 | |
| LEEERPFAIEQVTGM | 106 | O95757 | |
| DMEPRTVEINRELSD | 1671 | Q8NI35 | |
| ERAEVMEPGITTELV | 4251 | Q15413 | |
| MATRKDTEEEQVVPS | 1 | Q5VZP5 | |
| LDPMESVREETVNLT | 336 | Q6UWL2 | |
| AVMETAVEALPLVEA | 866 | Q6ZN55 | |
| MAEEQDLSEVELSPV | 1 | P56693 | |
| EMVVDSVLEDIVNSV | 1001 | O15015 | |
| SEMQEEEVEISLPRF | 276 | O75830 | |
| SMRVPDSLDDVEVVQ | 906 | Q9H254 | |
| DMAQVPLEDESVDVA | 346 | O43159 | |
| ERKPTVDAEEAQRMT | 81 | A6NLC8 | |
| EDEVERVITIMQNPR | 61 | P62269 | |
| MIESQEPVTFEDVAV | 1 | Q2M218 | |
| EPAVERREMLESVNV | 251 | Q9HBG4 | |
| SVTLDPNEEEMLEVI | 351 | Q8TCN5 | |
| RITSAPDMEDILTES | 76 | Q99598 | |
| EQRDVEVVAAPVEAM | 196 | Q9BXU3 | |
| EVTVDPNTVAAREME | 201 | Q96NL1 | |
| ATQMVLASEDDRLPV | 226 | O94979 | |
| DPINERRVFEMVVNT | 1026 | Q8IY18 | |
| MASELEPEVQAIDRS | 1 | Q8IWV8 | |
| QESDVEMAEAPASVR | 141 | A6NGD5 | |
| KEERDDIPAQVAMVT | 411 | P36508 | |
| VMIDLEPTVVDEVRA | 66 | Q9NY65 | |
| MLTVFALTEDDPQEV | 246 | P57678 | |
| ISEDEIIDRMPVITA | 236 | Q9C099 | |
| TEAMRVIGFSPEEVE | 256 | B0I1T2 | |
| VTEIPDTLREDQMRD | 161 | Q13287 |